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Glossary of Terms 
 
Term Definition 
Antero-posterior Relating to or directed from front to back 
Diaphysis Mid section of a Long bone between 
metaphyses 
Distal Situated away from the centre of the body 
(opposite proximal) 
Endoprosthesis An artificial body part (prosthesis) housed 
entirely within the body 
Epiphysis End part of a Long bone 
Femoral Of or relating to the femur 
Femur Long bone in the upper leg, between the hip 
and knee 
Humeral Of or relating to the humerus 
Humerus Long bone in the upper arm, between the 
shoulder and elbow 
Lateral Situated on one side or other of the body or of 
an organ, especially in the region furthest from 
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Medial Situated near the median plane of the body or 
the midline of an organ (opposite lateral) 
Medio-lateral  
Metaphysis End part of a Long bone, between epiphysis 
and diaphysis 
Orthoroentgenogram/Scanogram A radiographic technique used for showing 
true dimensions by moving a narrow 
orthogonal beam of X-rays along the length of 
the structure being measured. 
Osteosarcoma / Osteogenic Sarcoma A cancerous, malignant bone tumour 
Proximal Situated nearer to the centre of the body 
(opposite distal) 
Resection Surgical removal of tissue or part of an organ 
Tibia Lone bone in the lower leg, between the knee 
and the ankle 
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MRI Magnetic Resonance Imaging 
Ti6Al4V Medical Grade Titanium (6% Aluminium, 4% 
Vanadium) 
UHMWPE Ultra High Molecular Weight Polyethylene 
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1. Introduction 
Limb salvage surgery for the treatment of osteosarcoma in the skeletally immature 
necessitates the development of an endoprosthetic replacement, capable of extending at a 
rate comparable to that of natural growth without surgical intervention.  
Osteosarcoma occurs predominantly in the extremities, involving either the distal or 
proximal epiphyses of a Long bone and the adjacent joint. While osteosarcoma can develop 
at any age, it is more frequently initiated by and associated with the adolescent growth 
spurt in skeletally immature individuals. In order to prevent the spread of the cancer to 
other regions of the body, surgical resection of the tumour is required. This removal of a 
section of the Long bone (distal or proximal) and its adjacent joint compromises the function 
of the limb involved, which historically necessitated amputation of the limb above the 
tumour site. Advances in chemotherapy, surgical techniques and biomedical engineering 
have allowed for the development of limb salvage surgery as an alternative to amputation. 
Limb salvage surgery is achieved through the replacement of surgically removed bones and 
joints with endoprostheses. In the case of skeletally immature patients, a further problem 
presents as the removed proximal / distal tumour involves the removal of the epiphyseal 
plate, resulting in diminished growth capacity of the bone and ultimately limb length 
inequality. This limb length inequality must be prevented / recovered to avoid gait 
disturbances and resultant back pain.  
Over the past 30 years, a variety of different extendible endoprostheses have been 
developed, with the goal of overcoming limb length inequality as well as improving the 
patient’s quality of life. Earlier devices, while able to prevent limb length inequality required 
repeated invasive surgery in order to achieve extension. Repeated surgeries incur 
considerable financial costs and expose the patient to significant risk of infection. As a 
result, subsequent devices have sought to overcome such risks, developing non-invasive 
means of extension, which in turn reduces the duration and need for hospital visits. 
Stanmore Implants Worldwide has contributed greatly to the progressive development of 
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endoprosthesis (Stanmore Mark V JTS). While the Mark V overcomes the risks associated 
with repeated surgeries, it requires physician facilitated periodic extension which results in 
infrequent large extensions to recover limb length inequality. 
Although currently available extendible endoprostheses have overcome the need for 
repeated surgical extension procedures, they require physician facilitated extensions, which 
results in increased costs as well as infrequent large extensions that strain soft tissues 
surrounding the device. In addition, currently available devices commonly contain 
ferromagnetic materials which have a detrimental effect on MRI image quality, excluding it 
as a means of follow-up assessment. Ideally, a device containing no ferromagnetic materials 
would improve follow-up assessment of the tumour site through MRI compatibility. As such, 
there is a need to develop a non-ferromagnetic device capable of carrying out frequent 
minor extensions comparable to natural growth. Such a device would reduce the costs 
associated with hospital visits and physician facilitated extension procedures, as well as 
permitting accurate monitoring of the cancer site through MRI.  
This dissertation details the design of an extendible endoprosthesis overcoming some of the 
issues mentioned above. The scope is limited to the design and development of such an 
extendible endoprosthesis and its control. While it is expected that this device would attach 
to both a joint replacement at one end as well as the remaining length of the Long bone at 
the other, the design of the interfaces is not covered in this dissertation. For this reason, the 
device will also be referred to as an endoprosthetic growth module mechanism. 
In order to convey the need for extendible endoprostheses, this dissertation begins with a 
background in order to give an understanding of the nature and location of bone cancer 
together with its diagnosis and subsequent treatment, as well as the problems that ensue. 
Extendible endoprosthetic replacements have proven to be an effective means of treating 
osteosarcoma in skeletally immature patients and, as such, a description of historical and 
current devices is provided, indicating the areas for improvement. After assessment of these 
designs, the requirements for the design of a new extendible endoprosthesis are 
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to prove the design concept, the procedures and results of several tests are presented, 
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2.1. The Long Bone 
The skeletal system provides a means of support and protection for the various organs 
housed within the human body. Of the several types of bone that contribute to the skeletal 
system, only Long bones are of particular relevance to this dissertation and the 
development of an extendible endoprosthesis for limb salvage surgery in cases of 
osteosarcoma. These Long bones provide support and structure to the limbs, offering 
moment arms to attaching muscles, enabling motion and environmental interaction. Long 
bones are distinguished through the observation of dimensions, defined as possessing 
dimensions in which the length exceeds the diameter (Tortora & Grabowski 2003). The Long 
bone is the dominant type present in the extremities, with examples including the Humerus 
(upper arm), the Femur (upper leg), and the Tibia (lower leg). 
A typical Long bone can be divided into several distinct regions, contributing to the growth 
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2.2. Growth 
Biological growth and ageing necessitates the generation of new cells, which occurs through 
cellular division. This process occurs more rapidly in the early stages of an individual’s life, 
up and until the realisation of adulthood, after which cellular division takes place merely as 
a means of replacing worn-out or dying cells, as well as facilitating repairs to injuries (What 
is Cancer - Childhood Cancers n.d.). In the case of longitudinal growth of a Long bone, this 
growth is facilitated by and occurs at the epiphyseal plate, located between the epiphysis 
and metaphysis at both distal and proximal ends of the bone (Figure 2). Cells located in the 
epiphyseal plate multiply and differentiate, resulting in the progressive lengthening of the 
diaphysis. Closure of this epiphyseal plate and hence cessation of growth typically occurs at 
an age of 14.2 and 15.4 years for females and males respectively (Tupman, G S 1962). 
Through investigation of a sample size of 100 children (50 females & 50 males), Anderson et 
al (1963) obtained valuable data for predicting the growth of Long bones in the lower 
extremities. Measurements were carried out at least once a year for the eight years prior to 
cessation of growth (Anderson, Green & Messner 1963). Dimensions of the femur and tibia 
were established through orthoroentgenograms (commonly known as scanograms), with 
both the proximal and distal epiphyses included in the measurement (Anderson, Green & 
Messner 1963). 
The following two graphs (Figure 3 and Figure 4) are based on the source data collected by 
Anderson et al (1963) (Appendix A-1). Both show the comparison between male and female 
dimensions against chronological age up to the point of skeletal maturity, Figure 3 
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Additionally, Anderson et al (1963) investigated the rate at which this growth occurs. This 
rate of growth for the femur and tibia in both males and females (Appendix A-2) is indicated 
in Figure 5 and Figure 6. 
 
Figure 5: Comparison of male/female annual growth rates (Femoral) 
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2.3. Cancer 
The controlled process of growth and reparation of cells can get out of control, typically 
resulting in the development of cancer (What Is Cancer? 2009). The cancerous cells differ in 
that the DNA is damaged and cannot be repaired, making these cells superfluous (What Is 
Cancer? 2009). Replication of these cells continues and as these cells outlive healthy ones 
(What is Cancer - Childhood Cancers n.d.), it results in the development of excess tissue, 
referred to as tumours or neoplasms, which can be cancerous, fatal or harmless (Tortora & 
Grabowski 2003). A cancerous neoplasm is called a malignant tumour or malignancy, 
characterised by the ability to undergo metastasis and spread cancerous cells to other parts 
of the body (What is Osteosarcoma? 2009) (Tortora & Grabowski 2003). As the tumour size 
increases it begins to compete with healthy tissue for blood supply, to the detriment of the 
normal tissue which decreases in size and dies (Tortora & Grabowski 2003). In order to 
prevent the spread of the damaged cells (cancer), treatment is necessary, often through 
chemotherapy and/or surgical intervention (resection). 
Malignant tumours originating within the connective tissue of the human body are referred 
to as sarcomas, occurring in muscle, bone, fat, as well as soft tissue (Board 2008). More 
specifically, cancer occurring within bone is referred to as Osteosarcoma (or Osteogenic 
Sarcoma (What is Osteosarcoma? 2009)). Osteosarcoma is most frequently found in the 
immature bones of children and adolescents, typically arising in the ends of Long bones 
(Lewis 2005), due to the high concentration of replicating cells, resulting in the destruction 
and weakening of bone tissue (Board 2008). While osteosarcoma can originate in any bone 
of the body, the most common sites for development are outlined in Table 1 (What is 
Osteosarcoma? 2009)(Board 2008)(Mehlman & Cripe 2008)(Schindler et al. 1997)(Dominkus 















11 | P a g e  
 
Table 1: Osteosarcoma prevalence and location 
Bone Osteosarcoma Prevalence Location 
Femur 42 % 25 % Proximal 
75 % Distal 
Tibia 19 % 80 % Proximal 
20 % Distal 
Humerus 10 % 90 % Proximal 
10 % Distal 
 
Statistically, the occurrence of osteosarcoma is slightly higher in males (5.2 million p.a) than 
in females (4.5 million p.a) (Mehlman & Cripe 2008). While it is extremely rare in young 
children (0.5 per million per year in children < 5), incidence increases with age, dramatically 
so in adolescence corresponding to the adolescent growth spurt (Mehlman & Cripe 2008). 
Specific frequency relating to the occurrence of osteosarcoma in children has been captured 
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Figure 7: Osteosarcoma frequency 
While the frequency of occurrence differs somewhat between racial groups, it is of no 
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2.4. Detection and Diagnosis  
Crucial to the effective treatment of cancer is its early detection. While cancer is often 
difficult to detect, imaging techniques have proven invaluable to the early detection 
thereof. Imaging techniques employed are not only necessary for detection, but also vital to 
the determination of the precise location and stage of the cancer, fundamental to the mode 
of treatment. In addition, imaging facilitates the assessment of a particular treatment's 
efficacy as well as the monitoring of recurrence. (Cancer Imaging n.d.)(Board 2009) A variety 
of imaging techniques are employed for the detection and monitoring of cancer, outlined 
below. 
2.4.1. Radiography 
X-rays are the most common method employed in medical imaging. Two-dimensional 
images are produced as a result of the varying absorption rates of different bodily tissues. 
Different materials may be brought into focus by varying the intensity of the X-ray (Cancer 
Imaging n.d.). Images of bony or dense structures appear clear, while those of soft tissues or 
organs are of much lower quality (Tortora & Grabowski 2003).  Observed abnormalities can 
only indicate the possibility of cancer. 
2.4.2. Computed Tomography (CT)  
Formerly known as Computerized Axial Tomography (CAT scan), CT scans employ computer-
controlled X-rays to generate images. The distinct advantage of CT is the ability to generate 
visualisations of soft tissues and organs with significantly more detail than conventional 
radiography. In addition, multiple CT images may be assembled to produce three-
dimensional views. (Tortora & Grabowski 2003)  
2.4.3. Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging (MRI), through the use of magnetic fields and radio frequency 
pulses, produces very detailed two or three-dimensional computer images of organs, soft 
tissues, bone and various other internal body structures (Tortora & Grabowski 2003). 
Through the ability to accurately differentiate between abnormal (diseased) and normal 
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to alternative imaging techniques such as X-ray, ultrasound and computed tomography (CT) 
scans (MRI of the Body (Chest, Abdomen, Pelvis) n.d.). The accurate imaging provided by 
MRI allows physicians to diagnose and monitor tumours within the body. MRI is a relatively 
safe means of imaging the body, however implanted ferromagnetic medical devices may 
malfunction or cause problems during an MRI exam (MRI of the Body (Chest, Abdomen, 
Pelvis) n.d.), affecting the magnetic field and either distorting the images or shifting 
position. 
2.4.4. Sonography 
Sonography is used to observe the size, location, and actions of organs as well as blood flow 
through vessels. High-frequency sound waves reflected by body tissues are converted into 
an image (Tortora & Grabowski 2003). Sonography is a very safe, non-invasive and painless 
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2.5. Treatment 
Prior to the advent of chemotherapy in the 1970s, the dominant mode of treatment for 
malignant bone tumours often resulted in amputation (What is Osteosarcoma? 2009) (Lewis 
1986). Subsequent developments in the medical field have seen improvements in 
chemotherapy as well as diagnostic techniques. This has resulted in higher survival rates of 
the majority of children with osteosarcoma of the Long bones, which in turn has 
necessitated the development of limb salvage treatments yielding better quality of life than 
that of amputation (Delepine et al. 1998)(Schindler et al. 1997) (Schindler et al. 1998). No 
difference has been observed between the survival rates of limb salvage surgery and 
amputation, even with the higher rate of local recurrence in cases of limb salvage (Grimer, 
Taminiau & Cannon 2002) (Schindler et al. 1997).  
Amputation has a variety of alternate treatment options, including autograft, allograft, bone 
distraction, rotationplasty, and endoprosthetic replacements (Grimer 2005), all of which 
show positive functional results (Delepine et al. 1998). Limb salvage techniques typically 
carried out in older child osteosarcoma patients such as autograft, allograft and bone 
distraction are not suitable where there is a high likelihood of considerable limb length 
discrepancies (Neel et al. 2003). As such, treatment options differ where skeletal immaturity 
of the patient is a factor, due to the majority of tumours being located around the epiphyses 
and that resection often results in limb length discrepancy. Surgical options to recover or 
prevent limb length discrepancy include shortening the contralateral limb, over lengthening 
of a prosthesis at the time of implantation, contralateral epiphysiodesis or the use of 
extendable prostheses allowing dynamic leg length equalisation over time (Dominkus et al. 
2001) (Letson et al. 2003). Treatment of child osteosarcoma presents a surgical challenge to 
permit the patient to grow/age as normally as possible (Grimer 2005), favouring extendible 
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2.5.1. Amputation 
The limb is removed above the site of osteosarcoma, including a wide margin and reducing 
the likelihood of recurrence. Following healing of the surgical site, the patient is fitted with a 
conventional prosthesis. The cosmetic result of an amputation for distal osteosarcoma is 
shown in Figure 8 below. In the majority of cases, amputation results in the removal of the 
knee, resulting in poor functioning and gait disturbances with the fitted prosthesis.  
  
  
Figure 8: Amputation for distal osteosarcoma of the 
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2.5.2. Rotationplasty 
Rotationplasty presents advantages over amputation, including improved function through 
knee joint substitution, and the absence of phantom pain that is common to amputations 
(Grimer 2005). In the 1970s, Salzer and Kahn began applying rotationplasty as an alternative 
to amputation in the treatment of malignant bone tumours around the knee. Having first 
been described by Borgreve (1930) for the treatment of ankylosis of the knee joint, 
rotationplasty was subsequently adopted by Van Ness (1950) for cases of congenital defects 
of the femur (Wicart et al. 2002).  
Rotationplasty can be used in the treatment of proximal and distal osteosarcoma of the 
femur as well as that of the proximal tibia, following the removal of the tumour and 
associated joint. In the case of distal femoral osteosarcoma, the remaining healthy distal 
tibia together with the foot is rotated 180o and attached to the residual proximal section of 
the femur, fusing the tibia and femur together to act as a new femur. In treatment of 
proximal osteosarcoma, the remaining healthy leg is rotated 180o with the knee joint 
replacing the position and function of the hip joint, while the tibia serves as the new femur. 
In both cases, the 180o rotation is necessary to allow the ankle to serve as a knee 
replacement. Rotationplasty treatment of proximal tibial osteosarcoma is carried out in the 
same way as that for distal femoral osteosarcoma.  
Following successful treatment, the patient is then able to make use of a below-knee 
amputation prosthesis, and has improved function compared to amputees. An example of 
the cosmetic result following rotationplasty for treatment of distal femoral osteosarcoma is 
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2.5.3. Endoprosthesis 
The use of extendible endoprosthetic replacements for skeletally immature patients with 
bone tumours has become an acceptable and safe method of limb salvage, exhibiting local 
recurrence rates of between 5 and 10 %, comparable to that of amputation surgery 
(Schindler et al. 1997) (Cool et al. 1997) (Unwin & Walker 1996). Additionally, the use of 
extendible endoprostheses facilitates patient emotional acceptance, overcoming the 
undesirable and severe cosmetic results of amputation and / or rotationplasty and their 
subsequent orthotics (Letson et al. 2003) (Unwin & Walker 1996). 
The goal of expandable endoprosthetic reconstruction is to provide limb salvage surgery in 
children with malignant primary tumours of bone, while ensuring little to no limb length 
inequality. Allowing for the maintenance of leg length equality while the patient is growing 
as well as preserving the limb is a distinct advantage compared with alternative methods of 
treatment (Unwin & Walker 1996). 
Figure 10 below shows the surgical implantation of an extendible endoprosthesis, as well as 




Figure 10: Limb sparing reconstruction with HMRS extendable endoprosthesis, implantation (Left) and condition after 9 
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3.1. Historical Development 
Limb salvage surgery following tumour resection is the preferred treatment in cases of 
osteosarcoma in skeletally immature patients. Osteosarcoma is typically located in either 
the distal or proximal region of the Long bone (Figure 2), with resection resulting in the 
removal of one or both epiphyseal plates of the bone. The removal of one or both epiphyses 
results in diminished growth capacity of the bone, which in the case of the tibia and femur, 
leads to limb length inequality. This inequality affects the gait cycle and biomechanical 
loading of the body, resulting in damage to body joints such as the hip and spine (Letson et 
al. 2003). Extendible endoprostheses were developed in order to overcome the length 
inequality between the affected limb and the contralateral healthy limb through periodic 
adjustments to the extendible endoprosthesis, matching the length of the contralateral 
unaffected limb (Unwin & Walker 1996).  
A large variety of extendible endoprostheses have been developed, revised and improved 
on over the past 30 years. The motivation for development has been the improvement of 
patient quality of life through the reduction in revision surgeries for prosthesis extension 
which increases both the risk of infection (Unwin & Walker 1996), and financial implications. 
This design progression has resulted in three distinct categories of extendible 
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Table 2: Categories of extendible endoprostheses 
Type Description Advantages Disadvantages Examples 
Modular Extension achieved and controlled 
through insertion of specifically sized 
modular segments. 
- Solution to limb length inequality 
resulting from reduced growth 
capacity. 
- Requires regular highly invasive 
surgery. 
- Regular and repeated invasive 
surgery poses significant risk of 
infection. 
- Major financial implications due 
to repeated surgeries. 
- Kotz Modular Femoral and Tibial 
Reconstruction (KMFTR) 
- Howmedica Modular 
Reconstruction System (HMRS) 
- Stanmore Mark II & III 
Minimally-
invasive 
Extension achieved and controlled 
through advancing a drive screw 
mechanism or similar. 
- Solution to limb length inequality 
resulting from reduced growth 
capacity. 
- Improved surgical extensi n 
procedures, requiring minimally-
invasive surgery. 
- Surgery is required to produce an 
extension of the device. 
- Risk to patient from regular and 
repeated surgery. 
- Major financial implications due 
to repeated surgeries. 
- Lewis Expandable Adjustable 
Prosthesis (LEAP) 
- Stanmore Mark IV 
Non-
Invasive 
Extension achieved and controlled 
externally to the patient. 
- Solution to limb length inequality 
resulting from reduced growth 
capacity. 
- Extension achieved externally; no 
surgery required 
- No hospitalisation required. 
- No notable disadvantages to the 
concept of non-invasive 
extendible endoprostheses 
- Phenix 
- Stanmore Juvenile Tumour 
System (JTS) 
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Unwin et al (1996) investigated the use of extendible endoprostheses in the treatment of 
Long bone osteosarcoma. The occurrence of osteosarcoma and its location was highlighted 
in Section 2.3, however extendible endoprostheses are not used in all cases of Long bone 
osteosarcoma. Table 3 below shows the frequency with which these devices are used and 
their location, with the majority of extendible endoprostheses being used in the distal 
femur. 
Table 3: Use of extendible endoprostheses 
Location of Extendible Endoprosthesis Frequency (%) 
Femur Proximal 8.9 
 Distal 62.5 
 Proximal & Distal 1.8 
Tibia Proximal 16.7 
Humerus Proximal 4.8 
 Distal 1.2 
 Proximal & Distal 4.2 
 
While the earlier modular designs facilitated limb salvage, avoiding amputation, the regular 
extension procedures required invasive surgery. One of the most devastating and serious 
complications in replacement surgery is that of deep infection which increases with the 
number of surgical procedures (Delepine et al. 1998) (Schindler et al. 1998). This 
disadvantage of the early designs encouraged the development of extendible 
endoprostheses which achieve extension through minimally-invasive procedures and, more 
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Stanmore Implants Worldwide is an orthopaedic company founded in 1949 and based in 
Stanmore, Middlesex, England. The company designs and manufactures both custom and 
standardised orthopaedic implants (focusing on the restoration of limb and joint functions). 
Stanmore has contributed considerably to the development of extendible endoprostheses, 
having developed the first such device in 1976 (the Mark I) and continued to revise and 
improve the design of extendible endoprostheses up to present day (Unwin & Walker 1996). 
Following the Mark I, Stanmore has revised and developed a further four generations of 
extendible endoprosthesis mechanisms, introducing a ball bearing mechanism in 1982 
(Mark II) which was followed by the ‘C’ collar type in 1988 (Mark III) (Unwin & Walker 1996). 
Stanmore revisited and modified the mechanism of the early design by Scales and Sneath, 
introducing a minimally-invasive extendible endoprosthesis in 1991 (Mark IV) (Unwin & 
Walker 1996). Further development by Stanmore resulted in the introduction of the Mark V, 
a non-invasive extendible prosthesis in 2006 (Gupta et al. 2006)(Gupta et al. 2006). While 
many other manufactures have also contributed to the development, the designs are similar 
to those of Stanmore and, as such, a review of the designs developed by Stanmore provides 
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3.2. Mark II (1982)  
The Mark II extendible endoprosthesis consists of titanium alloy components, a hollow inner 
shaft and piston housed within an outer shaft. Extension is realised through the introduction 
of ball bearings into the hollow inner shaft, forcing a telescopic piston to extend, resulting in 
advancing the inner shaft’s protrusion from the outer. 
Tungsten Carbide ball bearings (ø 6.35 mm) are inserted into the threaded angled entry port 
and forced into the hollow inner shaft by a threaded introducer (Unwin & Walker 1996); 
insertion of each, results in the medical grade titanium alloy piston (Ti6Al4V) extending by 
6.35 mm (Schindler et al. 1997). Later versions incorporating the ball bearing mechanism 
were modified to include a decreased angle in the entry port, and bilateral anti-rotation 
keys (Schindler et al. 1997), preventing rotation of the inner shaft relative to the outer. 
Additional modifications included the machining of two grooves, permitting the use of a 
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Experience with the device was gained through implantation at various locations, 
predominantly distal femur, followed by proximal femur and tibia, as well as distal and 
proximal humerus (Unwin & Walker 1996). Numerous complications arose from the use of 
the Stanmore Mark II device. The invasive procedure necessary to expose the expansion 
mechanism and allow insertion of ball bearings resulted in a risk of infection. At the same 
time, this risk was significantly increased through the repeated surgery required for 
maintenance of limb length equality (Unwin & Walker 1996). The use of ball bearings limits 
the minimum expansion, and any further expansion, to graduated increments of 6.35 mm, 
resulting in overextension at the time of surgery (Unwin & Walker 1996). Although 
overextension would be negated over time through the continued growth of the 
contralateral limb, initial fixed flexion deformities of the knee were observed (Unwin & 
Walker 1996). In addition to the physiological complications, the mechanism itself also 
presented difficulties with jamming of the mechanism that occurred frequently due to 
fractured segments of the ball bearing, resulting from high point contact loading (Unwin & 
Walker 1996). Such jamming of the telescopic mechanism necessitated modifications to 
accommodate a distraction tool, reducing the loads on the bearings at the time of 
lengthening. However, this modification did not overcome the frequent mechanical failure 
due to ball bearing fracture within the mechanism (Unwin & Walker 1996)(Schindler et al. 
1998). Such common mechanical failure finally resulted in the device being superseded by 
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3.3. Mark III (1988)  
The Mark III device comprises of titanium alloy components, namely a piston contained 
within a hollow shaft. Extension is achieved through the successive addition of ring spacers 
placed on the telescopic shaft of the piston (Schindler et al. 1998), facilitating and 
maintaining increased piston extension. 
A distraction tool facilitates the extension of the mechanism. The jaws of the distraction tool 
are inserted into the two grooves on the endoprosthesis, the intramedullary stem and the 
hollow shaft housing the piston. The distraction tool forces the piston to extend from within 
the hollow shaft. The achieved extension of the mechanism is maintained by the insertion of 
titanium alloy (Ti6Al4V) ‘C’ clips of variable length (typically 6 mm) on the telescopic shaft of 
the piston (Schindler et al. 1998)(Unwin & Walker 1996)(Schindler et al. 1997). On each ‘C’ 
clip are lugs which mesh with a corresponding recess, preventing rotation of the clip relative 
to the shaft. 
 
 
Figure 12: Mark III modular extension device (Unwin & Walker 1996) (Schindler et al. 1997) 
 
A significant disadvantage of the Mark III device was the invasive procedure necessary for 
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expose the grooves on the mechanism as well as permit extension, while through each 
successive extension procedure, the relative displacement of the grooves increased. This 
necessitated progressively larger incisions for following expansion procedures (Schindler et 
al. 1997). In addition, the lengthening could only be carried out in set graduations of 6 mm 
and, like its predecessor the Mark II, such inflexible extension increments resulted in over 
lengthening, over loading surrounding tissue and caused fixed flexion deformities of the 
knee. This device was similarly superseded by an extension mechanism, the Mark IV, in an 
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3.4. Mark IV (1991); Revision of Mark I  
The Stanmore Mark IV endoprosthesis consists of a CoCrMo extension module incorporated 
into a hollow titanium alloy (Ti6Al4V) sleeve. The extension module is comprised of a 
telescopic worm wheel screw gearing mechanism, operated with a screw driver. ‘Extension 
modules of the Stanmore Mark IV prosthesis are available in three diameters (15, 20 and 30 
mm), with the smallest allowing the production of a minimal shaft diameter of 20 mm’ 
(Schindler et al. 1998). Overall extension limited to approximately 12 cm, depending on the 
original length of the prosthesis. (Schindler et al. 1998)  
Extension is achieved through a minimally-invasive procedure, exposing the hexagonal slot 
for the drive. Operation of the drive with a screwdriver results in the piston extending from 




Figure 13: Worm drive mechanism (Mark I & IV) 
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In studying the use of the Stanmore Mark IV minimally-invasive endoprosthesis, Unwin et al 
(1998) report no complications with the device, recognising the significant reduction in the 
length of hospital stays after lengthening procedures (Unwin & Walker 1996). 
The Mark IV minimally-invasive endoprosthesis saw a return of the original design employed 
by the Mark I developed by Scales and Sneath as part of Stanmore in 1976, the Mark I 
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3.5. Mark V JTS  
JTS drive unit was developed to provide a means of controlling extension of an 
endoprosthesis non-invasively. This drive unit produces a controlled expansion of the 
prosthesis without a need of for surgery (Stamore Implants n.d.). 
Similarly, by employing a power screw mechanism to jack apart two shafts, the Stanmore 
Mark V JTS endoprosthesis achieves limb lengthening non-invasively, driven by a rare earth 
NdFeB alloy disc magnet, operating through a gearbox (Gupta et al. 2006). The gearbox itself 
is composed of stainless steel coated in titanium nitride and lubricated with liquid paraffin 
(Stamore Implants n.d.).  The shafts of the device are manufactured from titanium (Stamore 
Implants n.d.).  The Stanmore Mark V JTS is available in different length options: 50, 70 and 
90 mm, providing a maximum extension length of 60 mm (Gupta et al. 2006). Dimensions of 
the JTS dictate that the minimum length of resection sufficient to accommodate the 
prosthesis is 170 mm (Gupta et al. 2006). The Stanmore JTS Extendible Endoprosthesis is 
shown in Figure 15 below. JTS drive specifications are detailed in Appendix C-3. 
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A lengthening procedure involves the use of an external drive unit, generating a rotating 
magnetic field. The rotating magnetic field induces synchronous rotation of the magnetic 
disc contained within the endoprosthesis, providing the gearbox with an input torque which 
is magnified to drive the power screw mechanism (Gupta et al. 2006). The resulting 
extension of the device is achieved non-invasively. 
 
Figure 15: Stanmore JTS extension rate (Stamore Implants n.d.) 
The JTS device has significant advantages over previous designs, particularly the non-
invasive nature of the device, allowing for extension procedures to be carried out in an out-
patient setting. In addition, the endoprosthesis provides controlled and measurable 
lengthening. During extension there is no noticeable feeling of any vibrations, heat or 
stretching of tissues for small amounts of extension (Stamore Implants n.d.). 
The external drive unit (magnetic coil) is a cumbersome and expensive piece of equipment 
and, as such, requires that extension of the patients’ limb is carried out in a hospital setting. 
The need for a physician to carry out extension procedures means that extensions can only 
be carried out sporadically, every six months in the case of the Mark V. These characteristics 
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4.1. Summary of Design Requirements 
A variety of aspects have been considered in order to improve and overcome some of the 
disadvantages of the extendible endoprostheses currently available, specifically the 
incompatibility with MRI and the inability to monitor and carry out frequent minor 
extensions. These aspects are crucial to the design and functioning of the endoprosthesis, 
and are described in further detail in the following sections. 
Table 4: Summary of design requirements 
Category Details 
 Specification Value Units 
Dimensions Diameter 28 mm 
 Overall Length (Max) 200 mm 
 Extension Capacity (Max) 100 mm 
Distraction Linear Force (Min) 500 N 
 Antero-Posterior Moment 9.5 BWcm1 
 Medio-Lateral Moment 6.7 BWcm1 
 Torsion 1.3 BWcm1 
Material Endoprosthesis Ti6Al4V - 
 Seals UHMWPE2  - 
 Motor As supplied  
 Gearbox As supplied  
Operation Non-invasive - - 
Life Span  5 yrs  
1BW – Body Weight 
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4.2. Dimensions  
Fundamental to the design of an extendible endoprosthetic femoral replacement are the 
dimensions of the femur and, more specifically, the typical resection dimensions that the 
device intends to replace. As in the case of a normal femur, the endoprosthesis must not 
impinge on the surrounding muscle and tissue.  
The relevant dimensions are the diameter, length and capacity for extension. The minimum 
diameter of the femur is located mid-way along the diaphysis, approximately φ 28.1 mm, 
while the average overall length of the femur is approximately 433 mm and 470 mm for 
females and males respectively (Section 2.2). However, in the case of limb salvage surgery, 
the dimension of the resected section of the femur is more specific to the design of an 
endoprosthesis if it is to serve as a replacement. Typically, the removal of osteosarcoma 
together with reasonable margins to avoid recurrence, results in an average resection 
length of 115 mm (ranging 80-200 mm) either proximally or distally (Kapukaya et al. 2000). 
While the overall dimensions of the endoprosthesis must be limited to a diameter of φ 28 
mm and an overall length of < 200 mm, the device must also be capable of providing a 
reasonable amount of extension. Reasonable extension, in this case, is deemed to be of 
sufficient amount to allow for a significant time span between revision surgeries, limiting 
risks and financial costs associated with surgery. Based on the data collected by Anderson et 
al (1963) (Appendix A-1), the remaining growth for both the femur and tibia has been 
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Figure 16: Remaining femoral growth at consecutive chronological ages 
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The remaining growth indicated in Figure 16 and Figure 17 account for that in both the 
proximal and distal epiphyses, however the growth rates of epiphyses differ slightly. The 
remaining distal femoral and proximal tibial growth for both males and females are shown 
in Figure 18 and Figure 19 respectively. 
 
Figure 18: Distal femoral growth remaining 
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Osteosarcoma can develop at any chronological age, however the occurrence increases with 
age up to maturity (Section 2.3). It is not possible to predict at what age the extendible 
replacement would be required and thus should ideally provide for the maximum possible 
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4.3. Biomaterials  
Biomaterials are defined as ‘any substance (other than a drug) or combination of substances 
synthetic or natural in origin, which can be used for any period of time as a whole or part of 
a system which treats, augments or replaces tissue, organ or function of the body’ (Snyder & 
Helmus n.d.). Such materials are required for the design of an endoprosthesis so as not to 
induce an inflammatory response in the patient which could lead to tissue necrosis (Teoh 
2007).  
In establishing the required biomaterials, certain aspects of the material must be 
considered, including biocompatibility, practicality, imaging compatibility and sterilisation 
compatibility. 
 
4.3.1. Biocompatibility and Practicality 
Metals 
Used in applications requiring rigid and high strength support, common alloys include 
austenitic stainless steels, cobalt-chrome alloys including molybdenum based alloys, 
tantalum and titanium. These materials are relatively easy to machine. 
Polymers 
A wide variety of biopolymers are used in a similarly wide range of applications. The more 
commonly used polymers include but are not limited to silicone, poly-ethylene and 
tetraflouroethylene. Use of biopolymers within the desired endoprosthesis is limited to 
seals and cable insulation. 
Silicone elastomers have proven to be chemically stable, however it does form molecular 
bonds with lipids which, in the long term, results in the material becoming rigid and brittle 
(Szpalski, Gunzberg & Mayer 2002). The properties of silicone make it a useful material for 
electrical applications such as wire insulation (Kutz 2009).  Additionally, silicone remains 
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Temperature Sensors n.d.). Although considered biologically inert, rare allergic reactions to 
silicone have been reported (Oprea et al. 2009), causing adverse inflammatory responses, 
including tissue degradation (Bigata et al. 2001). 
Ultra-high molecular weight polyethylene (UHMWPE), having been used in orthopaedics 
since 1962, is a distinctive material due to its notable properties including chemical 
inertness, lubricity, impact resistance, abrasion resistance and radiation tolerance (1000 
kGy) (Kurtz 2004) (Nordian n.d.), making it a favourable choice of polymer for device sealing. 
Typically used in electrical insulation applications, mechanical properties of Ethylene-
TetrafluoroEthylene (ETFE) include flexibility, chemical inertness, impact resistance and 
abrasion resistance (Thermometrics, Precision Temperature Sensors n.d.). ETFE has an 
excellent radiation tolerance of 1000 kGy (Nordian n.d.) and, as such, is the most suitable 
biopolymer for cable insulation. 
 
4.3.2. Imaging Compatibility 
Ferromagnetic materials are known to have adverse effects on MRI, resulting in distorted 
images. While structural components of the endoprosthesis are to be fabricated from 
biocompatible and non-ferromagnetic materials, the materials encased within the device, 
although not biocompatible, must contain limited amounts of ferromagnetic materials to 
avoid imaging complications. 
 
4.3.3. Sterilisation Compatibility 
Any implant must be sterilised to prevent introducing bacteria into the body. A variety of 
sterilisation techniques exist including steam, ETO and Gamma (Teoh 2007). As such, the 
extendible endoprosthesis must be compatible with at least one mode of sterilisation, 
permitting thorough sterilisation without any detriment to materials and / or electronics 
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Steam Autoclaving 
The original method of sterilising biomedical implants was that of steam sterilisation or 
autoclaving. The device to be implanted is exposed to pressurised steam at 120 oC for 
approximately 15 to 30 minutes, after acquiring the correct temperature (Davis 2003). 
Caution is necessary with this method given the high temperatures as some polymers and 
adhesives may undergo softening or melting (Davis 2003). In order to effectively sterilise, 
the steam must be exposed to all surfaces of all components. 
Ethylene Oxide  
A low-temperature means of sterilisation compatible with a large range of materials. 
Components are exposed to either pure or diluted EtO at 30 to 50 oC for 2 to 48 hrs (Davis 
2003). The toxicity of EtO presents as a disadvantage for use as a sterilisation method (Davis 
2003). In order to effectively sterilise, the EtO gas must come into contact with all surfaces 
of all components, as in the case of autoclaving. 
Gamma Ray 
Ionizing radiation of gamma rays from a source of cobalt-60 isotope provides a method for 
the sterilisation of implants. Cobalt-60 radiation is an advantageous method as it is rapid 
and reliable and, in addition, radiation is not absorbed by components (i.e. materials are not 
radioactive following sterilisation) (Davis 2003). When a level of between 25 and 40 kGy has 
been absorbed by the implant, it is deemed to be sterilized and free of bacteria (Davis 
2003). As the gamma rays are able to penetrate the material of the components, it is not 
necessary for all surfaces of all components to be exposed as in the case of steam and ETO 
sterilisation. All polymers are affected by radiation, some more than others with many 
effects considered negligible. Polymers incompatible with radiation include Polyacetal, 
Polypropylene and Teflon (Nordian n.d.).  UHMWPE exhibits an increase in strength due to 
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4.4. Loads  
The forces and loads to be experienced by an endoprosthetic replacement present a 
significant design consideration. If the implant is to serve a purpose and best restore normal 
bodily function, it must be able to withstand the stresses introduced by typical activities. 
Typical loading on the femur involves axial stresses in supporting body mass. Activities such 
as walking, stair ascent and descent, and jogging result in additional axial loads, bending 
moments and torsional moments on the femur, all of which the device must be capable of 
withstanding in order to cater for limb salvage surgery and preservation of function. Axial 
loading also occurs during extension due to the resistance of muscles and tissue. The 
expected forces imparted to the extendible endoprosthesis can be divided into two 
categories, namely distraction and functional forces, detailed below. It is possible to 
consider these two types of forces separately as extension of the Long bone is intended to 
be carried out in a relaxed position, which excludes the influence of functional forces and 
vice versa. 
Essential to the design of the endoprosthesis is the resistance to failure. The intended 
location of the device means that revision/replacement poses significant risk and difficulties, 
and failure of any component within the device prior to scheduled revision surgery is 
unacceptable. Allowing for the achievement of reasonable extension, it is expected that the 
device would be implanted for approximately 5 years. In this time, the endoprosthesis must 
resist both static and fatigue failure due to normal loading of the femur as well as loads due 
to distraction (extension). 
 
4.4.1. Distraction Loads 
In an effort to realise the resistance to expansion, Meswania et al (1998) studied the in-vivo 
distraction forces on an extendible endoprosthetic replacement, investigating 34 extendible 
endoprostheses implanted in patients aged 4 to 18 years, yielding a total of 76 extension 
measurements (Meswania et al. 1998). The study was carried out on a modular type of 
endoprosthesis in both the femur and tibia, as these required regular invasive surgery for 














43 | P a g e  
 
distraction tool was modified to include a Wheatstone Bridge arrangement of strain gauges 
to allow for measurement of the pure distraction force (Meswania et al. 1998). This study 
provided insight into the distraction forces compared with extension in the femur which has 
the greatest resistance to extension due to the greater muscle mass compared with other 
Long bones. 
Distraction forces were recorded at 1 mm extension increment up to 9 mm, over an 
extension interval of 10 s for both the femur and tibia (Meswania et al. 1998). Additionally, 
to investigate the effects of creep recovery of the soft tissues, further recordings were 
carried out at 30 s intervals (Meswania et al. 1998). 
The results for femoral distraction are shown in Figure 20 below. 
 
Figure 20: Distraction loading of femur vs. extension 
The initial soft tissue and muscle loading on the femoral modular endoprosthesis varied 
from 1 – 578 N, with an average of 135 N (Meswania et al. 1998). Continued investigation of 
loading at greater values of extension enabled Meswania et al (1998) to establish a linear 
relationship between load and extension. The variation in load at 6 mm extension was 
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502 N (Meswania et al. 1998). Regression analyses applied to the curves yielded an initial 
load of 122 N increasing to 516 N at 6 mm (Meswania et al. 1998).  
Figure 21 below shows the results of tibial distraction. 
 
Figure 21: Distraction loading of tibia vs. extension 
Initial loading of the tibial endoprosthesis ranged from 16 N to 422 N (mean 142 N), which 
increased to an average of 466 N at an extension of 6 mm (range 200 – 1092 N).  
In both femoral and tibial distraction measurements, upper and lower loads occur due to 
varying amounts of scar tissue and muscle mass of the 34 patients studied (Meswania et al. 
1998). 
Meswania et al (1998) also investigated the influence of tissue relaxation on the distraction 
loads. While previous data presented shows distraction loads for extension increments at 10 
s intervals, Figure 22 below shows the effects of increasing the time interval between 
extensions to 30 s, compared to that of 10 s intervals. The force difference is negligible at 
extensions below 3 mm but increases with larger extensions due to tissue stiffening 
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Figure 22: Tissue relaxation after 30s pause after each 1 mm extension (Meswania et al. 1998) 
 
From Figure 22 it can be seen that small extensions require significantly lower distraction 
forces, further improved by tissue relaxation between extensions. It would be advantageous 
for the design to cater for such conditions, providing extension at a rate comparable to 
natural growth, achieving minor extensions frequently in contrast to large periodic 
extensions. While the study presented by Meswania et al (1998) provides a reasonable 
prediction of average distraction forces, the influence of scar tissue resulting from massive 
surgery can affect the distraction force required. 
Although the device is i tended to carry out frequent minor extensions, it should also cater 
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4.4.2. Functional Loads 
Of all the Long bones, the femur experiences the greatest functional loading and, as such, is 
most relevant to the design capabilities of an extendible endoprosthetic replacement. 
Designed for femoral loads, the device would be more than adequate for replacing other 
Long bones. 
The loading on the femur has been mathematically modelled by a variety of authors, 
including but not limited to Duda et al (1997), and Frey Law & Shields (2004). While these 
calculated data are advantageous in its/their application to any number of subjects, many of 
the assumptions regarding muscle action, joint contact points, and other factors introduce 
uncertainty. In contrast, in-vivo telemetry studies generate valid measurements of forces in 
implants (Taylor & Walker 2001). 
Using strain gauges mounted on distal femoral replacements in two patients (shown in 
Figure 23) and tracking the patients for 2.5 years following implantation, Taylor et al (2001) 
documented the in-vivo loads (axial, bending and torsional) experienced by the femur under 
various activities (Appendix A-4): walking, stair ascent and descent, and jogging.  
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The variation in forces and moments observed by Taylor et al (2001) are shown in Figure 24 
below for two gait cycles. Three distinct axial loading peaks occur through a gait cycle, the 
first (0.9-1.1 BW) immediately before heel strike, the second (1.9 BW) and third (2.4 BW) 
during middle and late stance. The peak AP and ML moments are 6.7 BWcm and 4.4 BWcm 
respectively. Axial torque peaks at 0.8 BWcm. 
 
Figure 24: Forces and moments during gait cycle 
These data indicate the typical loading to be expected on the femur during walking, stair 
ascent and descent, and jogging. However, various other common daily activities such as 
climbing stairs result in considerably higher loading on the femur. The peak axial force, net 
moments (combined anterior-posterior (AP) and medial-lateral (ML) Moments), as well as 
torsional moments during these activities, are shown in Figure 25, Figure 26 and Figure 27 
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Figure 27: Peak torsional moments in the femur during various activities 
From the charts above, it can be seen that jogging results in peaks in the femoral axial force 
of 3.09 BW as well as the net moment, 11.5 BWcm. Ascending stairs similarly causes femoral 
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4.5. Drive  
A variety of different drive mechanisms have been and are employed in previous and 
current devices, including ratchet mechanisms driven by screw drivers or tibial rotation, 
magnetic coupling, as well as electro-mechanical mechanisms using small electric motors. 
All of the aforementioned drive mechanisms require gearing of some sort to develop the 
significant linear force required to carry out an extension.  While ratchet systems are 
simplistic, they either require minimally-invasive surgery to perform extensions or cannot be 
controlled accurately (as in the case of tibial rotation). Ideally, in order to minimise patient 
discomfort, extensions must be carried out non-invasively. This necessitates the use of an 
electrical or magnetic drive system, both of which are employed in currently available 
devices. The nature of operation of these drives is that they require ferromagnetic material, 
which is detrimental to imaging techniques crucial to the accurate diagnosis of cancer, such 
as MRI. It is therefore necessary to search for an alternative to ferromagnetic materials, 
while still being able to perform extensions remotely and non-invasively. The recently 
developed rotary piezo motor provides for such a scenario. These motors are capable of 
developing high torques while containing no ferromagnetic material and are an ideal choice 
for the drive mechanism. However, in contrast to magnetic coupling, the use of a motor 
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4.6. Power  
The intended location of the device limits the options available as a means of powering the 
piezo motor within the device. While battery power is an option, it requires a considerable 
amount of space, of which there is minimal. Furthermore, given the frequency of operation 
and the intended life span of the device, a sufficiently small battery is unlikely to store 
enough power for operation. It is therefore necessary to obtain power from a source 
external to the body/patient. This further presents an issue in that an electrical link between 
the motor and the power source is needed. It would be unwise to pass an electrical cable 
through the skin and deep into the body tissue as the risk of infection is great. Inductive 
coupling across the skin would overcome this barrier and, making use of a power source 
external to the body/patient such as the wall outlet, means there is essentially an unlimited 
supply and the inefficiencies of wireless power transfer are of no concern. The wireless 
power transfer would be achieved through a primary coil placed externally against the skin, 
while the secondary receiving coil is placed subcutaneously. When the axes of the coils are 
aligned, power is transferred from the primary coil to the secondary, generating an 
alternating current in the secondary coil. The frequency of the inductive coupling must not 
result in cellular damage or thermal effects. The electromagnetic spectrum and the effect of 
the various frequencies on body tissues are shown in Figure 28. The internally placed piezo 
motor requires a direct current and, as such, the alternating current generating in the 
secondary receiving coil must be rectified. In addition to powering the motor to develop 
extension of the device, a means of control is required to regulate and monitor the amount 
of extension developed at any stage. A conceptual flow diagram of the proposed circuitry is 
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Figure 29: Proposed drive powering and control components 
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4.7. Feedback and Control 
The endoprosthesis is intended to match the growth of the contralateral limb, preventing 
limb length discrepancy. The growth rate of a normal healthy femur (the contralateral 
femur) varies considerably with skeletal age (Section 2.2) therefore any extension of the 
endoprosthesis must be controlled to match the growth of the healthy contralateral limb. 
The magnitude of extension can be controlled by the time over which the device provides a 
constant extension rate, as well as allowing feedback from the device itself to precisely 
monitor the rotation of the motor. 
In order to best match the normal growth of the femur, frequent minor extensions are 
required (daily extensions). It is unrealistic for the patient to be expected to make frequent 
visits to the physician in order to achieve this ‘natural growth’ and, as such, it is necessary 
for the patient to perform these operations from home, requiring the control to be as 
simple and self-explanatory as possible. 
The controller would be required to act as the extension prescription. A computer program 
facilitates physician interaction with the controller (Section 5.2.3). The physician having pre-
programmed the controller with the required overall extension desired over a period (e.g. 
six months), the controller would calculate the daily extension required to achieve the 
overall extension for the period. Safety measures would also be required on the controller 
to limit patient interference as much as possible, including ensuring accurate extension of 
the device, limiting/preventing over extension, as well as preventing operation of the 
controller with a different endoprosthesis. A flow diagram of the device control logic is 
shown in Figure 31. 
Allowing feedback from sensors within the extendible endoprosthesis could also provide 
valuable data, providing further data on in-vivo distraction forces, as well as functional 
loading. The circuit components necessary for the control and data capture of the device are 
biologically incompatible and as such must be completely sealed from the surrounding body 
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4.8. Extension 
It is clear from the study of in-vivo distraction forces by Meswania et al (1998) (Section 
4.4.1) that minor extensions coupled with tissue relaxation results in significantly lower 
tissue tension and stiffening. Ideally, the rate of extension of the endoprosthesis should be 
reduced to mimic the natural rate of growth as realistically as possible. Such a progressive 
and slow rate of extension would result in no damage to tissues through distraction. 
In the case of current devices, extension procedures are carried out periodically with 
relatively large extensions, 6 mm at six month intervals (Stanmore Mark V). Ideally, in an 
effort to reduce the resulting strain on muscles and tissues, growth should be matched to 
that of a normal femur, carrying out minute extensions at high frequency (daily). This 
extension would be achieved in a similar fashion to previous and current devices available 
using a screw mechanism; rotational motion converted into linear translation.  
Based on the data collected by Anderson et al (1963) (Section 2.2), the approximate daily 
growth rates, and therefore the ideal extension rates for the femur and tibia, have been 
calculated, shown in  Figure 32 and Figure 33 respectively. Growth rates shown are the 
approximate distal or proximal growth rates and are based on the growth rate of the 
combined epiphyses. It can be seen that the maximum growth rate required is 















57 | P a g e  
 
 





































































58 | P a g e  
 
4.9. Sealing 
The intended location of the endoprosthesis will result in the device being continuously 
bathed in bodily fluids. At this stage of the design, both the motor and gearbox are not of 
custom design and, as such, are likely to contain biologically incompatible materials that 
cannot come into contact with the surrounding tissues and bodily fluids. In addition, the 
components used in the electronic control circuitry make use of materials that are similarly 
incompatible with the body. As such, all components of the device must be completely 
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5. Prototype Development 
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5.1. Summary of Device Specifications 
Table 5: Summary of device specifications 
Category Details 
 Specification Value Units 
Dimensions Diameter 28.1 mm 
 Length < 170 mm 
Distraction Load Linear Force (max) 800 N 
Functional Load Axial 3.09 BW 
 Antero-Posterior Moment 9.5 BWcm 
 Medio-Lateral Moment 6.7 BWcm 
 Torsion 1.3 BWcm 
Material Endoprosthesis Ti6Al4V - 
 Seals UHMWPE - 
 Motor As supplied  
 Gearbox As supplied  
Operation 
Non-Invasive, wireless power 
and control - - 
Life Span  5 yrs  
Extension Possible Extension 70 mm 
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5.2. Extension 
The extension mechanism is required to: 
- Convert rotational motion to linear, and develop a longitudinal change in the 
dimensions of the endoprosthesis 
- Act as a structural component of the endoprosthesis enduring distraction and 
functional loading 
- Develop the linear force required for extension of the limb 
Developing extension through the use of a power screw allows for conversion of rotational 
motion to linear, additionally gearing the forces. The required telescopic extension of the 
endoprosthesis is to be achieved through rotation of an externally threaded shaft (drive 
shaft) contained within a matching internally threaded tube (extension shaft) whose 
rotation is prevented by set screws located in a further tube surrounding the power screw 
(cover shaft), thus converting the rotational power of the drive shaft into linear movement 
of the extension shaft. The power screw mechanism is shown in Figure 34, and is to be 
fabricated from medical grade titanium (Ti6Al4V). The end of the extension shaft 
(highlighted in Figure 34) is required to accommodate a threaded piston shaft used during 
the experimental phase of the device development. This indicated region of the prosthesis 
will be revised to accommodate components required for bone interface (which is outside 
the scope of this dissertation).  
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The power screw is required to endure the stresses resulting from both distraction and 
functional loading (Section 4.4.1 and 4.4.2 respectively), while occupying the least amount 
of space (Section 4.2). The distraction and functional forces are not intended to occur 
simultaneously as the patient is intended to be in a relaxed position during extension 
procedures. In both loading scenarios, the forces used in modelling the stresses in the 
device are based on those experienced by the femur, greatest of all the Long bones. A 
design capable of withstanding such loading would therefore be more than adequate for 
replacement of the tibia and / or humerus.  
The threads considered include: 













Lead     
(mm) 
M6 6 1 5.5 5 1 
M8 8 1 7.5 7 1 
M10 10 1.25 9.375 8.75 1.25 
M12 12 1.25 11.375 10.75 1.25 
*All threads considered are self locking, Appendix E-1 
The linear force required to overcome the resistance of muscle and tissue, and develop 
extension has been described in Section 4.4.1 for extensions ranging from 1-6 mm. The 
average required distraction forces at 0 mm and 6 mm extensions are indicated on the 
graph in Figure 35 together with the power screw input torque and corresponding linear 
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includes that required to overcome friction of the drive shaft collar that facilitates axial 
location (indicated in Figure 34). 
The output linear force of the power screw was calculated according to the following 
formulae (Shigley, Mischke & Budynas n.d.), detailed in Appendix E-2 and E-3. 
𝐼𝑛𝑝𝑢𝑡 𝑇𝑜𝑟𝑞𝑢𝑒 = 𝑇𝑅 + 𝑇𝑐  












Figure 35: Power screw linear force vs. input torque for various threads 
All threads considered are capable of overcoming collar friction and generating the linear 
force necessary for a 6 mm extension with an input torque <2.5 Nm. Based on the data 
presented in the graph, the M6x1 thread is the most suitable, offering the greatest 
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endoprosthesis, the threaded drive shaft must be sufficiently sized to avoid the possibility of 
fatigue. 
In the process of extending the femur, the resistance from muscles and soft tissues 
increases with the magnitude of extension. This, coupled with the stress due to the torque 
required for extension, results in complex stresses on the threads, which must be resisted. 
Similarly, thread stresses arise due to the axial forces experienced during various activities 
such as walking, jogging etc (max 3.5 BW). Figure 36 indicates the thread root stress 
developed as a result of axial loading, taking into account the torque required to develop 
the same axial force and overcome the friction of the drive shaft collar. 
The thread root stress was calculated according to the following formula (Shigley, Mischke & 
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The peak axial force experienced during distraction (avg 500 N, max 1500 N (Section 4.4.1)) 
is considerably lower than the maximum expected during functional activities such as 
jogging (max 2400 N for a 70 kg individual). It can be seen from the graph above that with 
an axial load of 2400 N, the resulting M6x1 thread stresses are in excess of the material 
endurance limit and, as such, susceptible to fatigue failure. The same axial force applied to 
an M8x1 thread results in a thread stress of approximately 380 MPa, below the material 
endurance limit. As such an M8x1 thread is the most suitable for the endoprosthesis, 
providing  sufficient mechanical advantage for extension and withstanding the maximum 
expected axial load without fatigue, based on reasonable activity (participation in active 
sports is rare for patients with endoprostheses (Grimer 2005)). 
The designed M8x1 threaded drive shaft, cover shaft and extension shaft are shown in 
Appendix D-1-10, D-1-12 and D-1-13 respectively. A brass prototype of the extension 
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5.3. Drive Unit 
The drive unit is required to: 
- Develop the necessary torque required to overcome the distraction loads of soft 
tissue and generate an extension of 6 mm (approximately 2 Nm for M8x1 thread, 
Section 5.1)  
 
Figure 37: Drive unit (Exploded View) 
 
5.3.1. Motor 
In order to ultimately achieve an endoprosthesis compatible with MRI, the motor used in 
the device must not contain ferromagnetic materials. Piezo motors are an ideal choice to 
ensure MRI compatibility, containing no ferromagnetic material. Rotation is achieved by 
sequentially activating radially spaced piezo crystals, in contrast to the magnetic field 
interaction of more commonly used stepper motors. 
The choice of motor is further limited by the space available for the endoprosthesis. Of the 
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requirements of the device (φ 28.1 mm, Section 4.2). The relevant properties of the two 
motors are shown in Table 7. 
Table 7: Piezo motor options 




DTI Piezo Motor 
#PMLL-18R 
Φ20 x 28 22 40 
Piezo Motor Piezo 
Legs R01S-12 
Φ23 x 27 80 90 
 
It can be seen from the table above that difference in dimensions is negligible compared to 
that of the stall/holding torque. In light of this, the Piezo Legs motor is the ideal choice for 
use in the extendible endoprosthesis. 
The characteristics of the Piezo Legs R01S-12 motor supplied by Piezo Motor Gmbh are 
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Figure 38: Piezo legs rotary motor characteristics 
The drive shaft requires an input torque of >2 Nm to perform an extension of 6 mm (Section 
5.1). The operating torque of the piezo motor alone is insufficient to develop the necessary 
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5.3.2. Gearbox 
In order to increase the output torque of the drive unit, the output torque of the motor 
must be geared. Again, dimensions are a constraint on the gearbox. Wittenstein Cybermotor 
Gmbh manufactures suitable sized and rated gearboxes for the task, a three-stage planetary 
gearbox GCP 022, available in Reduction Ratios (RR) of 64:1, 112:1 and 196:1 and rated to 
maximum torque of 3 Nm (Appendix C-1). All RR options make use of the three stages and 
as such the dimensions of the gearbox are unaffected (Appendix D-1-6). The gearbox output 
torque versus input torque is shown in Figure 39. 
 
Figure 39: Gearbox output torque vs. input torque 
Any of the three gearboxes shown in the Figure 39 is capable of generating the rated 
maximum torque of 3 Nm when coupled with the piezo motor output torque of up to 80 
Nmm (0.08 Nm). An input torque of 3 Nm to the screw mechanism yields an extension force 
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Figure 40 shows the extension rate of the endoprosthesis based on a drive unit consisting of 
the piezo motor and the RR196 gearbox. 
 
Figure 40: Extension rate vs. Piezo motor rotation velocity 
5.3.3. Transition Shaft 
As supplied, the piezo motor and gearbox connections were incompatible. The output of the 
piezo motor was a smooth shaft of smaller diameter than the gearbox input hole, and as 
such, a transition piece was required. 
 
Figure 41: Transition shaft 
The transition shaft (Appendix D-1-5) shown in Figure 41 was developed to facilitate 
connection and torque transfer between the motor and gearbox. In order to ensure efficient 
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piezo motor (Appendix D-1-3). Connection between the transition shaft and motor is 
facilitated by a corresponding internal single flat. Connection to the gearbox is achieved by 
an interference fit between the transition shaft and gearbox input smooth hole.  
5.3.4. Drive Unit Casing 
The drive unit casing (Appendix D-1-7) shown below in Figure 42 is required to house and 
isolate the drive unit (Figure 37) from the surrounding body fluid and tissues.  
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5.1. Functional Stress Analysis 
The endoprosthesis is required to withstand the typical stresses experienced by a femur 
during normal activities, including walking, ascending and descending stairs as well as 
jogging. 
The irregular shape of the endoprosthetic device results in different developed stress for the 
same loading and requires that it be separated into sections in which the material stresses 
can be calculated; 12 different sections shown in Figure 43, and cross-sectional areas in 
Figure 44. The distraction and functional loads are considered separately as extension 
procedures are to be carried out in the absence of functional loads. 
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Figure 44: Cross-sectional areas of endoprosthesis 
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Functional loading (as captured by Taylor et al (2001) of the femur results in a peak net 
moment on the femur during jogging (11.5 BWcm), and a peak torsional moment during 
stair descent (1.3 BWcm); Section 4.4.2. Based on this loading (for a 70 kg individual, 
Appendix A-5), the stresses in each of the 12 different cross sections are calculated to 
ensure that failure by fatigue is avoided, Figure 45. 
Stresses are calculated according to the formula (Shigley, Mischke & Budynas n.d.) below, 
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It can be seen that all 12 sections experience stresses far below the fatigue strength of 
medical grade titanium (approx. 350 MPa, Appendix A-2 Table 21) and as such both static 
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5.2. Power, Control and Feedback (Vicatos, Ginsberg & 
Parsons 2011) 
The electronic system is required to: 
- Couple motor drive energy through the patient’s skin 
- Generate signals suitable for motor operation (steps) 
- Monitor motor rotation 
- Permit programming by medical personnel 
- Optionally allow for in-vivo data capture 
- Withstand conditions associated with standard medical procedures including 
sterilisation and diagnostics. 
This electronic system can be separated into three distinct categories: Internal, External, 
and Program (allowing configuration). 
 
5.2.1. Internal 
Contained within the extendible endoprosthesis and implanted in the patient are a motor, 
motor drive circuit, power-receiving coil and regulation circuit, the power for which is 
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Shown in Figure 46, are the phased electrical signals required to cause rotation of the 
motor. Repeatedly supplied to the motor, these signals (phase A-D) generate rotation of the 
motor output shaft.  
In order to monitor the motor rotation, a current impulse is drawn from the motor drives’ 
power supply within the body which similarly causes a current impulse to be drawn from 
the external power supply. Monitoring the power consumption, the current impulses 
indicate the completion of the four ‘steps’ taken by the motor (corresponding to the four 
phases). The current impulse occurs shortly after the completion of Phase D pulse, also 
shown in Figure 46. 
Some of the materials contained within the motor and gearbox, together with the circuit 
components are likely to cause inflammatory responses due to bio-incompatibility. This 
resulted in the endoprosthesis being designed in such a way so as to isolate these parts, 
avoiding all contact with body fluids and in turn limiting the possible sterilisation methods to 
Gamma. The need to withstand ionizing radiation means that conventional microcontroller 
technology cannot be used as radiation damages the contents of many memory types 
including Flash and EEPROM. Additionally, the circuit components for internal placement 
must be as small as possible. In order to comply with these requirements, the circuit was 
approached differently, resulting in a hard-wired circuit for control rather than a program 
controlled one (shown in Appendix D-3). 
An alternating current is generated in the receiving coil (charge coil), implanted immediately 
beneath the patients’ skin, when coupled with the external power coil. This current is 
converted to direct current and the energy is briefly stored within capacitors. When a 
voltage sufficient to successfully turn the motor is reached, a voltage ‘pulse’ is generated. 
The four phases of the motor are then activated successively through time delay circuits. 
The final time delay circuit in the cascade results in the drawing of a current impulse from 
the charge coil, causing the capacitors to discharge. It is this current impulse which provides 
the feedback for monitoring of rotation. Following the current impulse, the capacitors begin 
charging again and the process repeats and the waveforms indicated in figure are generated 
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Further enhancement of the extendible endoprosthesis is achievable through the 
attachment of strain gauges to the titanium body, measuring extension force as well as 
functional loads. With the resulting data being transmitted across the skin, either by 
conventional radio techniques or through coded patterns of current impulses (similar to 
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5.2.2. External 
Using an Ergo case  (B7015209 – See Appendix D-4), shown in Figure 47, to house the 
external electronics, the unit can be strapped to the patient, the case curvature providing a 
snug fit with the limb.  
 
Figure 47: ERGO Case 
This close contact with the skin ensures the supply of an alternating magnetic field to the 
internal charge coil below the skin. The circuitry within this unit allows for monitoring of the 
internally generated current impulse, measuring the number of steps taken by the motor. 
There is no limit on the circuit components, as in the case of the internal electronics, 
because sterilisation of the unit is not required due to it being housed external to the 
patient. The circuitry operates according to the flow chart shown in Figure 31, Section 4.7. A 
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Figure 48: Block diagram of external electronic system 
The use of a microcontroller within the external unit allows for computer interface, typically 
USB. Various parameters can then be transferred to the unit and stored in memory, such as 
the total extension required over a given period, as well as limits on daily extensions. Each 
extension operation results in a count down on the total extension programmed, indicated 
to the user on an LCD mounted on the case (Figure 49). 
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LEDs present on the face of the ERGO case indicate coupling between the external drive coil 
and internal charge coil, failing which extension is not permitted. A single button on the unit 
allows the patient to begin an extension operation within the limits of the pre-programmed 
parameters. In the event that coupling is lost, the unit stores the amount of extension 
carried out and updates the remaining for the programmed period. An optional RFID reader 
allows for the unit to paired with and identify a specific endoprosthesis, ensuring the correct 
device is being extended. 
The drive frequency is selected to be in the 100 kHz to 1 MHz range, avoiding the ionizing 
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5.2.3. Program 
Medical personnel will be required to program the device (external control unit) by entering 
the amount of extension required and time frame into a computer based application, an 
example of which is shown in Figure 50 below. Having set extension parameters, the 
settings could be transferred to the control unit via USB or similar. 
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5.3. Sealing 
In order to prevent contact of body tissue and fluids with the gearbox, motor and drive 
electronics, sealing is required at three points, namely drive shaft, power cable and 
prosthetic joint connection. 
The seal between the extension module and the attaching prosthetic joint is outside the 
scope of this dissertation however, for the purposes of testing, this seal was modelled with 
an M24x1 threaded plug, as shown in Appendix D-1-2. This could be reduced to a standard 
Morse taper without the thread for attachment to a prosthetic joint. 
The wall of the drive unit casing is too thin to accommodate an effective means of sealing 
the electrical cable connecting the receiving coil under the skin and drive circuitry within the 
device.  
 
Figure 51: UHMWPE seal 
The UHMWPE drive shaft seal is above in Figure 51. The circumference of the seal is 
threaded, M24x1 (tight thread) and seals against the corresponding internal thread of the 
drive unit casing. A central hole through the seal is required for the drive shaft. Sealing at 
this point is achieved by a tolerance on both the drive shaft seal surface and seal central 
hole to generate an interference fit and still allow for rotation of the drive shaft. A more 
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5.4. Sterilisation 
The standard motor and gearbox provided by Piezo Motor and Wittenstein respectively, 
together with the custom drive electronics, contain biomedically incompatible materials and 
as such cannot come into contact with body tissue and or fluid. This requirement resulted in 
the development of seals to prevent this contact (Section 5.3). Effective sealing of the 
internal components presents difficulties to the sterilisation process, preventing the 
permeation of sterilising gases involved with autoclaving and ethylene oxide. As a result the 
only effective means of sterilisation is through gamma exposure. 
The materials chosen for the design of the endoprosthesis were based on their compatibility 
with gamma radiation however, the components required for drive and operation of the 
endoprosthesis were supplied as standard from manufacturers. The materials that make up 
the gearbox were disclosed by Wittenstein and are deemed gamma compatible with the 
exception of a polymer gear stage used, which could diminish the life span of the gearbox. 
The required operating lifespan of the gearbox is minimal compared to that predicted for a 
gearbox not exposed to gamma and, as such, the effect of gamma radiation can be 
considered negligible. Piezo Motor Gmbh is unwilling to disclose the nature of the 
components within the motor and hence the resistance to gamma ray exposure is unknown 
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5.5. Test Rig 
In addition to the design of the device itself, it was also necessary to design and fabricate a 
test rig (Figure 52 and Appendix D-2) for the device in order to test the linear force output of 
the device.  
The linear force of the endoprosthesis is measured by means of pressure change in a 
hydraulic cylinder. Attachment of the endoprosthesis to the hydraulic cylinder is facilitated 
by the internal thread at the end of the extension shaft which corresponds to that on the 
hydraulic cylinder. In order to ensure that the linear force of the device was transferred to 
the cylinder, backing plates were placed behind both the device and the cylinder. 
Additionally, to ensure axial alignment of the device and cylinder, a support/ guide plate is 
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6.1. Linear Force 
The test rig shown in Appendix D-2 was set up and the experiment carried out according to 
Appendix B-1. This experiment was necessary to confirm the predicted capacity for linear 
extension, developing the necessary forces required to extend a typical femur, overcoming 
the tension of muscles and tendons. It was envisaged that the device would be capable of 
generating sufficient force to develop an extension of up to 6 mm, accommodating both 




Figure 52: Linear force experiment apparatus 
The linear force test was carried out on the brass prototype excluding the UHMWPE seal, 
shown together with the testing apparatus in Figure 52. The results of this initial test are 
shown in the graph below (Figure 53). The force was calculated based on the pressure 
change in a hydraulic cylinder (sampled at 5 minute intervals) and, as can be expected, the 
linear force versus operating time increases exponentially due to the incompressibility (bulk 
modulus) of the hydraulic fluid. The maximum distraction force for this experiment was 
limited to 40 kg (390 N) due to the material limits of brass. It can be seen that the linear 
force reached the maximum 40 kg for this experiment. This result is congruent with the 
predicted capabilities of the device. 
Endoprosthetic Device  Hydraulic Cylinder  
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The rotational velocity of the piezo motor was recorded throughout the experiment and 
also sampled at five minute intervals together with the pressure readings. The RPM of the 
motor was measured visually, marking a point on the motor and timing a revolution. The 
variation of the motor RPM versus experiment time is shown the graph. It is noted that the 
RPM of the motor decreases linearly with time and/or device linear force. A further 
experiment (Appendix B-2) was developed to investigate this observation, and establish 
whether it was a result of strain on the motor, or merely a characteristic of the motor. 
The linear force test on the device was repeated on the brass prototype, including the drive
shaft seal. The results of which are shown in the graph below (Figure 54). A preload was
applied to the device and the force tracked over a shorter period compared to the initial
test. It can be seen from the graph that the results compare closely with those of the test
without a seal (Figure 55). However, it can be seen that the motor rotational velocity does
not compare similarly across both tests. This is attributed to the fact that the period for the
test without a seal is significantly shorter than that with the seal, indicating that the motor
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Figure 55: Linear force test without UHMWPE seal 
Following the successful results of linear force testing, the growth module mechanism was 
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Figure 56: The trial titanium endoprosthetic growth module mechanism 
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6.2. Piezo Motor Rotational Velocity 
Observation from the linear force experiments indicated that the motor RPM and the device 
linear force expressed an inverse relationship. Monitoring of extension is achieved through 
the electronic control circuitry of the motor, sending a pulse back on completion of one 
revolution irrespective of time. Although a decrease in rotational velocity has not effect on 
the operation, it was necessary to assess whether this was a characteristic of the motor or a 
result of strain due to the increasing loads which could mean that the motor would 
eventually seize. In order to examine this more closely, the piezo motor was operated alone, 
without any external loads on the output. The results of this experiment are shown below 
(Figure 57). 
The graph shows that the motor RPM decreases over time, tending toward a constant. This 
observation is similar to that observed in the linear force experiment (Section 6.1.) It is 
noted that in the absence of a motor load, the settled RPM of the motor is greater than that 
of the initial experiment. It is therefore apparent that the loading has an influence on the 
RPM of the motor, although this influence is not large and is unlikely to cause seizure of the 
motor. 
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6.3. Seal Testing 
6.3.1. Sealing 
The UHMWPE seal on the drive shaft is required to prevent the passage of bodily fluid, as 
contact with the biologically incompatible materials of the drive unit could result in a 
negative physiological response.  
Seal testing was carried out according to the experiment outlined in Appendix B-4. No fluid 
was seen to pass through the seal after a period of 48 hours under periodic rotation and 
flexing of the drive shaft. 
6.3.2. Frictional Torque 
In addition to frictional losses in the thread of the drive shaft, the drive unit must also 
generate torque to overcome the friction due to the UHMWPE seal. The investigation into 
the magnitude of this torque was carried out according to Appendix B-5.  
The device was assembled as shown in Figure 58, without the extension shaft and drive unit, 
allowing the drive shaft to rotate relative to the drive unit casing and cover shaft. The end of 
the drive shaft was clamped in a fixed position, and a mass attached to a screw extending 
from the cover shaft. The mass moment arm was varied until the drive unit casing and 
extension shaft rotated relative to the drive shaft, indicating that the frictional torque of the 
seal was overcome.  
The frictional torque of the seal was found to be between 28 and 36 Nmm (Appendix A-1-3), 
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Figure 58: Seal friction testing 
 
6.4. Inductive Power Transfer 
The driving circuit provided by Piezo Motor SE, designed to operate the piezo motor, 
generates a sinusoidal output for driving the motor's piezo crystals. Changing the drive 
signal to a square wave resulted in a significant space saving on the circuit board which was 
required due to the limited space available. As such it was necessary to establish whether a 
square wave could in fact drive the motor. Following correspondence with the manufacturer 
in confirming the operation of the motor under a square wave input, it was necessary to 
investigate the potential for inductive power transfer across biological tissue. 
Cow muscle tissue was used (cow shank) for testing of inductive coupling. The receiving and 
transmitting coils were placed on either side of a section of muscle tissue (Figure 59). The 
thickness of the tissue was gradually reduced until power transfer was achieved, 
approximately 10 mm. The drive frequency was maintained at 130 kHz, and as such there 
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Figure 59: Wireless power transfer across tissue 
 
6.5. Gamma Testing 
Gamma radiation is the expected method of sterilisation for the device and as such, the 
effects of this radiation on electronic components needed to be tested (Irradiation 
Certificate shown in Appendix H-1). 
6.5.1. Electronics 
Of all the electronics used in the drive circuitry, the only components sensitive to gamma 
radiation were the op-amps. The original op-amps (series LM358) used in the prototype 
circuitry failed after 25 kGy radiation. Following this result, two alternative op-amp series 
were tested (MC33078 and LM833). After irradiation (25 kGy) the op-amps were 
operational, but required more power than previously. The results of the LM833 were 
deemed to be inconclusive as this series had failed in the first test with the LM358 series.  
Based on the results of gamma irradiation, the op-amp chosen for the drive circuitry was the 
MC33078. The increased power demand of the op-amp is easily accommodated for in the 
power circuitry. 
6.5.2. Piezo Motor 
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6.6. MRI Testing 
A piezo motor was chosen for the drive unit in an effort to develop an endoprosthetic 
extension module compatible with MRI imaging. In order to test this compatibility, the 
extension module was subjected to a 3 Tesla MRI. To model the implant conditions and 
achieve contrast with biological tissues, the device replaced a section of bone within a cow 
shank (tibia), shown in Figure 60.  
 
Figure 60: Endoprosthetic device implanted in cow shank 
Figure 61 shows the image produced under MRI, a void exists along the length of the shank, 
corresponding to the location of the extension device. The ankle joint of the shank can be 
seen in the bottom of the image. The 3 Tesla MRI produced a dark shadow but no scatter 
artefacts as one would have expected from stainless steel parts. This result indicates that 
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7. Conclusion 
A literature review of the progressive development of extendible endoprostheses was 
carried out, with specific focus on those designed by Stanmore Implants Worldwide. 
Stanmore designs were focused upon as the company has contributed to all categories of 
extendible endoprostheses including modular, minimally-invasive and non-invasive, the 
latest being the Mark V JTS, categorised as non-invasive. The JTS overcomes considerable 
disadvantages of earlier designs, specifically the need for surgically facilitated extension. 
Extension is achieved non-invasively by a rotating magnetic field external to the body, 
inducing the rotation of an internal magnet, driving a power screw. The ferromagnetic 
materials contained within the JTS drive mechanism make it incompatible with MRI, limiting 
the diagnostic techniques available for follow-up. While surgery is not necessary to extend 
the JTS, it requires a cumbersome coil apparatus to be operated by a physician. As a result, 
the extensions are only carried out periodically, requiring large extensions (approximately 6 
mm at six months).  
Based on the review of both past and currently available devices, areas for improvement 
were noted, specifically relating to frequency of extensions and MRI compatibility. This 
required the development of a new extendible endoprosthesis. Before the development of 
the new design, the requirements of such a device needed to be addressed. Crucial design 
requirements include device dimensions, biocompatibility, sterilisation, loading, drive 
(including powering and control), extension rate and sealing.  
The overall length of the device limited to the typical tumour resection length of 115 mm 
(80-200 mm). Additionally, the maximum remaining femoral growth for an 8-year-old male 
patient is approximately 140 mm contributed by both the proximal and distal epiphyses, 
requiring that the device be capable of facilitating a maximum of approximately 100 mm 
(10-year old male distal femur, Section 4.2) of growth over the remaining period of growth. 
To provide this extension, the device must be capable of generating the linear force 
required to overcome muscle tension (avg. approximately 500 N at 6 mm). Additionally, the 
patient is expected to continue with typical activities such as walking, stair ascent and 
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the stresses resulting from these activities. The materials used for the device are limited to 
those that are biocompatible, as well as compatible with sterilisation techniques. 
Furthermore, the absence of ferromagnetic materials within the device allows for the use of 
MRI for follow-up assessment. Finally, the control, power and feedback of the drive 
mechanism were considered. 
The designed extension mechanism includes a piezo motor containing no ferromagnetic 
material and generating a stall torque of 80 Nmm. The torque of the motor is stepped 
through a gearbox (RR 196:1) resulting in the gearbox maximum output torque of 3 Nm 
(Rated Gearbox Torque). An M8x1 threaded drive shaft connected to the gearbox output 
shaft was chosen for the drive shaft capable of developing the linear force of 500 N required 
for an extension of 6 mm with 2 Nm of torque. The functional length of the device is 95 mm, 
and the cover and extension shaft lengths may be varied to suit the patient, allowing for 
different overall extension lengths.  
The drive unit for the device is powered and controlled wirelessly using inductive coupling 
across the patient's skin. A pulse is sent back from the motor after completing four phase 
pulses, activating the piezo crystals and turning the motor 4 μrad. In this way, the amount of 
extension achieved can be monitored. The external unit is designed to be pre-programmed, 
permitting the patient to carry out extension procedures at home with follow up visits with 
the physician scheduled periodically to assess progress. The ability to carry out extensions at 
home allows extensions to be carried out frequently (daily), achieving an extension rate 
similar to natural growth.  
Several aspects of the design required testing, specifically linear force, sterilisation 
compatibility, MRI compatibility, seal testing, wireless power transfer and device control. 
The capacity for extension was investigated through force testing, using a test rig and 
hydraulic cylinder measuring the force pressure. Sterilisation of the device is limited to 
gamma radiation and, as such, the radiation effects on certain components of the drive and 
control circuitry was tested to ensure compatibility. Similarly, MRI testing was carried out to 
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out to ensure that no fluids entered the drive mechanism, coming into contact with 
biologically incompatible materials.  
Linear force testing was carried out on the brass prototype, generating a 40kg extension 
force (limited due to material properties of brass), capable of effecting a 4 mm extension of 
the femur. The device has a predicted maximum extension force of approximately 800 N, 
and is capable of achieving extension > 6 mm under tissue resistance. 
The designed UHMWPE seal proved effective, preventing the penetration of fluids into the 
drive unit casing while permitting rotation of the drive shaft. The sealing contact between 
the seal and the drive shaft results in friction. A torque of between 28 and 36 Nmm is 
required to overcome this friction, having a negligible effect on the linear output force of 
the device. 
All electronic components used in the extendible endoprosthesis were operational following 
gamma irradiation (25kGy), confirming that the device is compatible with gamma 
sterilisation. 
Imaging of the extendible endoprosthesis was not possible using a 3 Tesla MRI, as it gave 
inconclusive results. 
The capacity for wireless power transfer was tested across muscle tissue. With a drive 
frequency of 130 kHz, transmission across approximately 10 mm of tissue was achieved 
without any thermal affects on the tissue. This result confirmed that the drive unit of the 
device can be powered wirelessly across the patient’s skin. 
Overall the designed device is an acceptable alternative to currently available extendible 
endoprosthesis. Added advantages to this device include the potential for MRI compatibility 
with little to no distortion effects, and the capacity for minor daily extension to be carried 
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Recommendations 
- MRI testing was carried out using a very powerful 3 Tesla MRI, which may be the 
reason the device could not be resolved in the images. It is recommended that 
further MRI testing be carried out, as images of previously designed medical grade 
titanium endoprosthesis have been achieved, even with the presence of 
ferromagnetic materials. 
 
- In the current design both the motor and gearbox were supplied as standard 
products from the manufacturer. It is recommended that these components be 
custom designed to exclude any ferromagnetic materials as well as to improve 
mechanical output and input connections to facilitate interface between the two. 
 
- The electrical cable linking the subcutaneous power receiving coil and the drive 
electronics housed within the drive unit casing must be sealed to prevent tissue fluid 
entering the drive unit casing. The minimal wall thickness of the designed 
endoprosthesis cannot accommodate an effective mechanical seal. As such, it is 
recommended that the cable pass through the attaching prosthetic joint (Figure 56). 
The attaching joint would have sufficient material and space for cable sealing, 
alternatively, special biocompatible ‘glue’ material is needed to provide sealing 
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A-1. Dimensions: Femur and Tibia  
Values for stature, length of femur and tibia at consecutive chronological ages, lengths measured from orthoroentgenograms and includes 
both proximal and distal epiphyses (Anderson, Green & Messner 1963). 
Table 8: Female dimensions; stature, femur and tibia 
Female Dimensions (50 Girls) (Anderson, Green & Messner 1963) 
Age Stature Femur Tibia 
yrs mm mm mm 
  Mean Std Dev     Mean Std Dev     Mean Std Dev     
      Max Min     Max Min     Max Min 
8 1281 47.8 1424.4 1137.6 331 16.3 379.9 282.1 263 13.9 304.7 221.3 
9 1338 47.8 1481.4 1194.6 350 17.1 401.3 298.7 280 15 325 235 
10 1399 52.4 1556.2 1241.8 370 18.2 424.6 315.4 298 16.7 348.1 247.9 
11 1466 59.3 1643.9 1288.1 392 20 452 332 316 18.4 371.2 260.8 
12 1532 63.6 1722.8 1341.2 411 21.2 474.6 347.4 332 19.5 390.5 273.5 
13 1583 61.4 1767.2 1398.8 424 21.2 487.6 360.4 342 19.4 400.2 283.8 
14 1608 61.6 1792.8 1423.2 431 21.5 495.5 366.5 345 19.7 404.1 285.9 
15 1623 60.2 1803.6 1442.4 432 21.8 497.4 366.6 346 19.8 405.4 286.6 
16 1629 61 1812 1446 433 22 499 367 346 20 406 286 
17 1638* 63.7* 1829.1 1446.9 433* 22.1* 499.3 366.7 347* 20* 407 287 
18 1649* 61* 1832 1466 433* 22.1* 499.3 366.7 347* 20* 407 287 
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Table 9: Male dimensions; stature, femur and tibia 
Male Dimensions (50 Boys) (Anderson, Green & Messner 1963) 
Age Stature Femur Tibia 
yrs mm mm mm 
  Mean Std Dev     Mean Std Dev     Mean Std Dev     
      Max Min     Max Min     Max Min 
8 1276 59.4 1454.2 1097.8 328* 15.3* 373.9 282.1 259* 15.5* 305.5 212.5 
9 1333 61.5 1517.5 1148.5 346* 17.8* 399.4 292.6 271* 18.6* 326.8 215.2 
10 1385 65.8 1582.4 1187.6 364 18.7 420.1 307.9 286 18.9 342.7 229.3 
11 1435 69.4 1643.2 1226.8 382 20.7 444.1 319.9 301 20.7 363.1 238.9 
12 1494 77.2 1725.6 1262.4 402 22.3 468.9 335.1 318 22.7 386.1 249.9 
13 1563 91.3 1836.9 1289.1 423 25.2 498.6 347.4 336 24.9 410.7 261.3 
14 1637 95.4 1923.2 1350.8 443 25.8 520.4 365.6 353 25.4 429.2 276.8 
15 1698 86.8 1958.4 1437.6 458 23.8 529.4 386.6 364 23.4 434.2 293.8 
16 1732 77.4 1964.2 1499.8 466 22.7 534.1 397.9 369 22.1 435.3 302.7 
17 1750 74.1 1972.3 1527.7 469 23 538 400 371 22.1 437.3 304.7 
18 1759 73.7 1980.1 1537.9 470 23.5 540.5 399.5 371 22.2 437.6 304.4 














A-4 | P a g e  
 
 
Table 10: Remaining growth in distal femur 
Remaining Distal Femoral Growth (mm) 
Age Female Male 
 
Average Max Min Average Max Min 
8 65 98 41 - - - 
9 52 86 31 - - - 
10 41 72 22 72 97 48 
11 28 47 16 61 84 38 
12 17 28 7 48 72 28 
13 7 15 1 29 57 16 
14 3 7 0 14 30 40 
15 0 4 0 4 10 10 
16 - - - 1 6 0 
17 - - - 0 2 0 
 
Table 11: Remaining growth in proximal tibia 
Remaining Proximal Tibial Growth (mm) 
Age Female Male 
 
Average Max Min Average Max Min 
8 41 60 25 - - - 
9 33 51 19 - - - 
10 26 43 11 46 67 30 
11 16 28 9 38 56 23 
12 8 15 3 30 47 16 
13 3 8 0 18 34 10 
14 0 3 0 7 22 1 
15 0 1 0 2 7 0 
16 - - - 0 3 0 
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A-2. Growth Rates: Femur and Tibia 
Table 12: Female growth rates; stature, femur and tibia 
Female Growth Rate 
Age 
Interval 
Stature Femur Tibia 
yrs mm mm mm 
  Mean Std 
Dev 
    Mean 
(pa) 












      Max Min     Max Min         Max Min     
8.5 57 7.7 80.1 33.9 20 2.8 28.4 11.6 1.667 0.056 17 2.9 25.7 8.3 1.417 0.047 
9.5 60 13.9 101.7 18.3 20 3.2 29.6 10.4 1.667 0.056 18 3.6 28.8 7.2 1.500 0.050 
10.5 67 17 118 16 21 3.5 31.5 10.5 1.750 0.058 18 3.8 29.4 6.6 1.500 0.050 
11.5 65 19.1 122.3 7.7 19 5.2 34.6 3.4 1.583 0.053 16 5.6 32.8 0 1.333 0.044 
12.5 52 22 118 0 14 6.7 34.1 0 1.167 0.039 10 6.3 28.9 0 0.833 0.028 
13.5 25 15 70 0 6 5 21 0 0.500 0.017 4 4.1 16.3 0 0.333 0.011 
14.5 14 11.5 48.5 0 2 3 11 0 0.167 0.006 1 2.4 8.2 0 0.083 0.003 
15.5 7 7.9 30.7 0 1 2 7 0 0.083 0.003 0 1.4 4.2 0 0 0 
16.5 4* 5.8* 21.4 0 0* 0.6* 1.8 0 0 0 0* 0.4* 1.2* 0 0 0 
17.5 2* 4.6* 15.8 0 0* 0* 0 0 0 0 0* 0* 0* 0 0 0 
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Table 13: Male growth rates; stature, femur and tibia 
Male Growth Rate 
Age 
Interval 
Stature Femur Tibia 
yrs mm mm mm 
  Mean Std 
Dev 
















      Max Min     Max Min         Max Min     
8.5 57 8.8 83.4 30.6 20* 2.7* 28.1 11.9 1.667 0.056 16* 2.2* 22.6 9.4 1.333 0.044 
9.5 52 9.1 79.3 24.7 18* 3.2* 27.6 8.4 1.500 0.050 15* 2.7* 23.1 6.9 1.250 0.042 
10.5 50 8 74 26 18 3.4 28.2 7.8 1.500 0.050 15 2.8 23.4 6.6 1.250 0.042 
11.5 59 16 107 11 19 4.2 31.6 6.4 1.583 0.053 17 4.2 29.6 4.4 1.417 0.047 
12.5 69 21.6 133.8 4.2 21 5 36 6 1.750 0.058 18 4.9 32.7 3.3 1.500 0.050 
13.5 74 20.2 134.6 13.4 20 5.2 35.6 4.4 1.667 0.056 17 5.8 34.4 0 1.417 0.047 
14.5 60 25.6 136.8 0 15 7.9 38.7 0 1.250 0.042 11 6.8 31.4 0 0.917 0.031 
15.5 35 23.7 106.1 0 8 7.3 29.9 0 0.667 0.022 5 7.7 28.1 0 0.417 0.014 
16.5 18 17.4 70.2 0 3 3.8 14.4 0 0.250 0.008 2 2.5 9.5 0 0.167 0.006 
17.5 9 10.4 40.2 0 1 1.7 6.1 0 0.083 0.003 0 0.8 2.4 0 0 0 
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A-3. Femur and Tibia Distraction Forces 
 
Table 14: Loads due to distraction for femur and tibia (Meswania et al. 1998) 
Loads due to Extension  
Femur Tibia 




Load Range Average 
Load 
Regression 
Load Upper Lower Upper Lower 
mm N N N N N N N N 
0 578 1 135 122 422 16 142 130 
1 734 10 196 188 534 47 196 189 
2 890 19 257 253 645 77 250 248 
3 1046 28 319 319 757 108 304 308 
4 1201 37 380 385 869 139 358 367 
5 1357 46 441 450 980 169 412 426 
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A-4. Femoral Loading for Various Activities 
 












Torque (BWcm) Speed 
 
  Peak Trough Peak Trough Peak Trough Peak Trough m/s 
Walking 
8-9 52 2.17 0.25 6.6 -1.2 4.3 -0.6 0.8 -0.4 1.1 
8-9 108 2.62 0.33 7.7 -1.3 5 -0.4 0.4 -0.5 1.17 
8-10 132 2.8 0.24 8.5 -0.8 4.4 -0.4 0.4 -0.6 1.32 
Ascending 
Stairs 
6-7 52 2.14 0.34 6.3 -0.4 5.4 -2 1.1 -0.2 0.45 
5-6 108 2.4 0.48 6.9 -0.4 4.9 -2.3 0.4 -0.4 0.47 
4-5 132 2.44 0.43 9 -1.3 3.7 -1.8 0.8 -0.7 0.51 
Descending 
Stairs 
4-6 52 2.68 0.34 7.1 -1.1 3.5 -1.6 1.3 -0.4 0.51 
4-5 108 2.9 0.52 6.6 -1.2 4 -2.4 0.9 -0.4 0.51 
4-6 132 3.09 0.45 9.5 -0.8 2.8 -1.9 1 -0.4 0.56 
Jogging 
6-8 52 3.08 0.46 8.3 -0.7 5.5 -1.9 0.9 -0.7 1.7 
8-9 108 3.11 0.65 7 -1.1 6.7 -2.3 0.3 -0.5 1.88 
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A-5. BMI: Male and Female 
Table 16: Mean BMI for males and females by age (Rosner et al. 1998) 
 Male Female 
Age BMI Std Dev Stature Body Mass * BMI Std Dev Stature Body Mass * 
yrs kg/m2  mm kg kg/m2  mm kg 
5 15.8 1.6 - - 15.6 1.8 - - 
6 16.0 1.7 - - 15.9 2.0 - - 
7 16.4 1.9 - - 16.2 2.2 - - 
8 16.8 2.3 1276 27.4 16.8 2.6 1281 27.6 
9 17.5 2.7 1333 31.1 17.5 3.1 1338 31.3 
10 18.2 3.2 1385 34.9 18.3 3.4 1399 35.8 
11 18.9 3.5 1435 38.9 19.2 3.7 1466 41.3 
12 19.5 3.6 1494 43.5 20.3 4.1 1532 47.6 
13 20.2 3.6 1563 49.3 21.0 4.1 1583 52.6 
14 20.7 3.6 1637 55.5 21.5 4.2 1608 55.6 
15 21.6 3.8 1698 62.3 21.9 4.2 1623 57.7 
16 22.1 3.7 1732 66.3 22.2 4.3 1629 58.9 
17 22.8 3.9 1750 69.8 22.5 4.5 1638 60.4 
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A-1. Experiment Results 
A-1-1. Linear Force 
Table 17: Results of linear force testing 
 
Time Resistance Voltage Current Pressure Load Speed 
       
Force Load True Load  
  
R V I P P F L 
  
 
min Ω V A Bar kPa N kg Cum. kg ~ RPM 
Zero 
 
249.4 1.1984 0.0048 0.4026 40.26 79.04 8.06 - - 
Start 0 249.3 1.1980 0.0048 0.4027 40.27 79.08 8.06 0.00 6 
 
10 249.2 1.2172 0.0049 0.4422 44.22 86.83 8.85 0.79 5 
 
20 249.2 1.2405 0.0050 0.4895 48.95 96.11 9.80 1.74 4.6 
 
30 249.1 1.2645 0.0051 0.5381 53.81 105.66 10.77 2.71 4.6 
 
40 249.0 1.2908 0.0052 0.5920 59.20 116.23 11.85 3.79 4.6 
 
50 249.0 1.3255 0.0053 0.6616 66.16 129.91 13.24 5.18 4.5 
 
60 248.9 1.3603 0.0055 0.7326 73.26 143.85 14.66 6.60 4.6 
 
70 248.9 1.3975 0.0056 0.8074 80.74 158.52 16.16 8.10 4.6 
 
80 248.8 1.4420 0.0058 0.8979 89.79 176.30 17.97 9.91 4.5 
 
90 248.8 1.4983 0.0060 1.0111 101.11 198.52 20.24 12.18 4.6 
 
100 248.8 1.5560 0.0063 1.1276 112.76 221.41 22.57 14.51 4.7 
 
110 248.7 1.6139 0.0065 1.2447 124.47 244.39 24.91 16.85 4.3 
 
120 248.7 1.6785 0.0067 1.3745 137.45 269.89 27.51 19.45 4.1 
 
130 248.7 1.7549 0.0071 1.5281 152.81 300.05 30.59 22.53 4.3 
 
140 248.7 1.8470 0.0074 1.7141 171.41 336.55 34.31 26.25 4.4 
 
150 248.6 1.9434 0.0078 1.9087 190.87 374.77 38.20 30.14 4 
 
160 248.6 2.0520 0.0083 2.1271 212.71 417.66 42.57 34.51 4 
 
170 248.6 2.1850 0.0088 2.3946 239.46 470.18 47.93 39.87 3.9 
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A-1-2. Motor Rotational Velocity 
Table 18: Results of motor rotational velocity testing 
Time 1 Rev (s) RPM 
0 9.8 6.1 
5 11.2 5.4 
10 12.3 4.9 
15 12.9 4.7 
20 13 4.6 
25 13.2 4.5 
30 13.2 4.5 
 
 
A-1-3. Seal Friction 
Table 19: Results of seal friction testing 
Seal  Mass (kg) Moment Arm (m) Frictional Torque(Nm) 
Sample 1 0.0908 0.0398<l<0.0406 0.03581 
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A-2. Properties of Medical Grade Titanium (Ti6Al4V) 
Table 20: Properties of Ti6Al4V (Titanium Ti-6Al-4V (Grade 5), STA n.d.) 
Physical Properties Value Units Comments 
Density 4.43 g/cc  
    
Mechanical Properties    
Hardness, Brinell 379 -  
Hardness, Knoop 414 -  
Hardness, Rockwell C 41 -  
Hardness, Vickers 396 -  
Tensile Strength, Ultimate 1170 MPa  
Tensile Strength, Yield 1100 MPa  
Elongation at Break 10 %  
Modulus of Elasticity 114 GPa Average Tension and Compression 
Compressive Yield Strength 1070 MPa  
Notched Tensile Strength 1550 MPa  
Ultimate Bearing Strength 2140 MPa  
Bearing Yield Strength 1790 MPa  
Poissons Ratio 0.33 -  
Charpy Impact 23 J V Notch 
Fatigue Strength 
160 MPa Kt (Stress Concentration Factor)= 3.3, Cycles 1e7 
700 MPa Un-notched, Cycles 1e7 
Fracture Toughness 43 MPa√m  
Shear Modulus 44 GPa  
Shear Strength 760 MPa Ultimate Shear Strength 
 
Table 21: Calculated endurance limit (Based on Dimensions and Loading) See Appendix E-7 
Endurance Limit Value Units Comments 
Max 406 MPa Φ 8 mm 
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B-1. Linear Force 
  
Aim To investigate the validity of predicted linear force of the designed device versus the actual 
linear force achieved in a practical application. 
Apparatus  The device, assembled  
 Hydraulic cylinder 
 Test Rig (see Appendix) 
 Pressure Transducer (8 Bar) 
 DC power supply 
 250 Ohm Resistance (240 Ohm and 10 Ohm resistors) 
 Conductive Wire 
 Digital Meter 
 Stop Watch 
 Hydraulic fluid (23?) 
Method - Prime cylinder with hydraulic fluid and mount pressure transducer, ensuring no 
air bubbles in the cylinder. 
- Assemble the test rig according to Diagram, including mounting of the hydraulic 
cylinder 
- Assemble test circuit according to diagram 
- Calibrate hydraulic cylinder and pressure transducer, checking zero error 
- Place extension device in test rig as indicated in diagram 
- Adjust to ensure zero load on the extension device 
- Attached piezo motor control device to the motor 
- Set DC power supply to 12 V 
- Measure resistance of resistors in series using digital meter 
- Measure zero load voltage, using digital meter 
- Turn motor on, beginning test 
- Sample resistance and voltage every 5 mins using the digital meter, further 
measure the rotational velocity of the piezo motor every 5 mins using the stop 
watch until the desired and predicted output force for brass is achieved 
- Record result in a spreadsheet, calculating pressure, at sample times, based on the 
voltage output of the pressure transducer 
- Based on the pressure reading of the transducer calculated the applied linear force 
Results 
The recorded data from the experiment are shown in Table 17, and presented graphically 
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B-2. Motor Rotational Velocity Characteristics 
  
Aim To investigate the variation in rotational velocity of the piezo motor with respect to time 
Apparatus  Piezo motor 
 Piezo motor driver  
 Stop watch 
Method - Connect the driver to the piezo motor 
- Initiate rotation of the piezo motor with the driver 
- At 5 min intervals record the rotational velocity of the motor 
Results 
















B-4 | P a g e  
 
B-3. Wireless Power Transfer 
  
Aim To investigate the capability of the external circuit in providing sufficient power to the 
internal circuitry to drive the motor. 
Apparatus  Drive assembly 
 Custom drive circuitry and receiving coil 
 External power circuitry including driving inductive coil 
 Power supply 
 Oscilloscope 
 Beef shank 
Method - Connect the external power circuitry to the power supply 
- Place the drive circuitry and receiving coil in the beef shank, under muscle and fat 
tissue  
- Starting with a large separation, align th  axes of the driving and receiving coils 
- Observe motor output, if no rotation observed, resect some tissue reducing 
separation distance and repeat test 
Results 
Motor rotation was achieved with a separation of approximately 10mm, yielding a positive 
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B-4. Seal Efficacy 
  
Aim To investigate the efficacy of the seal in preventing the passage of fluid. 
Apparatus  The device, assembled with UHMWPE seal and without the drive unit 
 Water 
 Red dye 
Method - Mix water and dye, pouring into the cavity for the drive unit 
- Leave for a period of two days under gravity, periodically rotating and flexing the 
drive shaft 
Results 
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B-5. Seal Friction 
  
Aim To investigate the torque required to overcome the static friction between the 
seal and the drive shaft. 
Apparatus  Two sample seals of type 2 
 The device, assembled without extension shaft and drive unit 
 Vice 
 Weights (90.8g) 
 M4 Screws of various lengths 
Method - Rotation of the drive shaft is prevented using vice grips, leaving the drive 
unit casing and cover shaft free to rotate relative to the drive shaft 
- An M4 screw is inserted into the corresponding hole in the cover shaft, 
and the device is rotated until the screw is horizontal 
- The fixed mass is suspended from the screw and the moment arm length 
adjusted until the applied torque is sufficient to overcome the static 
friction, at which point the length of the moment arm is recorded 
- Procedure repeated using second seal 
Results 
The torque required to overcome the friction was calculated according to 
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C. Equipment Specifications 
 
C-1. Gearbox ................................................................................................. C-2 
C-2. Motor .................................................................................................... C-4 
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C-1. Gearbox 
Table 22: GCP022 gearbox specifications 
  
Manufacturer/Supplier Wittenstein Inc 
1249 Humbracht 
Tel: (630) 540 5300 
Fax: (630) 736 6100 
Web: http://wittenstein-us.com/Motors.html  
Contact Thompson, Geoff 
Geoff.Thompson@wittenstein-us.com  
Product Motor Gearbox Unit GCP 022 (3 Stage) 
Ratio 196 
Nominal Output Torque (Nm) 1.5 
Peak Output Torque (Nm) 3 
Mass (g) 100 
Efficiency 0.85 
Mass Moment of Inertia (kgm2) 0.004 
Torsional Backlash (arcmin) 50 
Torsional Stiffness (Nm/arcmin) 0.20 
Temperature Range (0C) Max +90 
Protection Class 44 
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C-2. Motor 
Table 23: Piezo motor specifications 
  
Manufacturer/Supplier Piezo Motor  
Stålgatan 14 
SE-754 50 Uppsala 
Sweden 
Tel: +46 (0) 18-489 51 71 
Fax: : +46 (0)18-489 50 01 
Web: http://www.piezomotor.se/  
Contact Lindkvist, Olle 
olle.lindkvist@piezomotor.se  
Product Piezo Legs Rotary Motor 
Angular Range 360 deg 
Maximum Speed 14 RPM 
Resolution <1 μrad 
Max Voltage 48 V 
Stall Torque (max) 80 Nmm 
Holding Torque (max) 90 Nmm 
Surface  Bare metal 
Material Stainless steel 
Connector JST BM05B-SRSS-TB 
Mechanical Size 32 x 23 mm 
Weight 60 g 
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C-3. Stanmore JTS 
Table 24: Stanmore JTS specifications (Gupta et al. 2006) 
Component Specification Value Unit 
Gearbox (Epicyclic) Diameter 21.5 mm 
 Length 18.5 mm 
 Reduction Ratio 13061:1 - 
 Output Torque 4 Nm 
Magnetic Disc (NdFeB toroidal) Synchronous Speed 3000 RPM 
Power Screw Axial Thrust 1350 N 
 Pitch 1 mm 
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D-1. Endoprosthetic Growth Module Mechanism 
D-1-1. Device Assembly: Exploded 
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D-1-3. Piezo Motor 
 
  
. . 14 ' 
1 ~ I 
• I 
, 
















D-4 | P a g e  
 
D-1-4. Adaptor Plate 
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D-1-8. Drive Unit Casing: Detail A 
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D-1-9. Spacing Plate 
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D-1-10. Drive Shaft 
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D-1-11. UHMWPE Seal 
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D-1-13. Extension Shaft 
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D-2. Test Rig  
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D-2-3. Cylinder Backing 
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E-1. Thread Dimensions 
𝑑𝑚 = 𝑑 −  
𝑝
2  
𝑑𝑟 = 𝑑 − 𝑝 
Where  
𝑑 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑛𝑜𝑚𝑖𝑛𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚  
𝑑𝑚 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑚𝑒𝑎𝑛 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚  
𝑑𝑟 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑚𝑖𝑛𝑜𝑟 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚  
𝑝 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑝𝑖𝑡𝑐𝑕  𝑚  
 
E-2. Thread Torque 
𝜋𝑓𝑑𝑚 > 𝑙 𝑖𝑠 𝑡𝑕𝑒 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑠𝑒𝑙𝑓 𝑙𝑜𝑐𝑘𝑖𝑛𝑔 𝑡𝑕𝑟𝑒𝑎𝑑𝑠 
















𝑇𝑅 = 𝑟𝑎𝑖𝑠𝑖𝑛𝑔 𝑡𝑜𝑟𝑞𝑢𝑒 (𝑁𝑚) 
𝑇𝐿 = 𝑟𝑎𝑖𝑠𝑖𝑛𝑔 𝑡𝑜𝑟𝑞𝑢𝑒 (𝑁𝑚) 
𝐹 = 𝑙𝑖𝑛𝑒𝑎𝑟 𝑓𝑜𝑟𝑐𝑒 (𝑁) 
𝑑𝑚 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑚𝑒𝑎𝑛 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚  
𝑙 = 𝑡𝑕𝑒𝑎𝑑 𝑙𝑒𝑎𝑑 (𝑚) 
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𝑇𝑐 = 𝐶𝑜𝑙𝑙𝑎𝑟 𝑡𝑜𝑟𝑞𝑢𝑒 (𝑁𝑚) 
𝐹 = 𝑎𝑥𝑖𝑎𝑙 𝑙𝑜𝑎𝑑  𝑁  
𝑓𝑐 = 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑓𝑟𝑖𝑐𝑡𝑖𝑜𝑛 
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E-4. Thread Stress 




  𝜎𝑥 − 𝜎𝑦 
2
+  𝜎𝑦 − 𝜎𝑧 
2
+  𝜎𝑧 − 𝜎𝑥 
2 + 6 𝜏𝑥𝑦
2 + 𝜏𝑦𝑧
2 + 𝜏𝑧𝑥








𝜏𝑥𝑦 = 0 




𝜎𝑧 = 0 𝜏𝑧𝑥 = 0 
Where  
𝜎 ′ = 𝑉𝑜𝑛 𝑀𝑖𝑠𝑒𝑠 𝑆𝑡𝑟𝑒𝑠𝑠 (𝑃𝑎) 
𝐹 = 𝑎𝑥𝑖𝑎𝑙 𝑙𝑜𝑎𝑑  𝑁  
𝑑𝑟 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑚𝑖𝑛𝑜𝑟 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚  
𝑝 = 𝑡𝑕𝑟𝑒𝑎𝑑 𝑝𝑖𝑡𝑐𝑕  𝑚  
𝑇 = 𝑠𝑐𝑟𝑒𝑤 𝑡𝑜𝑟𝑞𝑢𝑒  𝑁𝑚  
 









+ 𝜏𝑥𝑦2  
𝜎𝑥 =
𝑀𝑦
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𝜎𝑦 = 0  
𝜏𝑥𝑦 =
𝑇𝑟




𝜎1 = 𝑝𝑟𝑖𝑛𝑐𝑖𝑝𝑎𝑙 𝑠𝑡𝑟𝑒𝑠𝑠  𝑃𝑎  
𝑀 = 𝑚𝑜𝑚𝑒𝑛𝑡  𝑁𝑚  
𝑦 = 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝑐𝑒𝑛𝑡𝑟𝑜𝑖𝑑 (𝑚) 
𝑑 = 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 𝑑𝑖𝑚𝑒𝑛𝑠𝑖𝑜𝑛 (𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟  𝑚 ) 
𝐼 = 𝑠𝑒𝑐𝑜𝑛𝑑 𝑚𝑜𝑚𝑒𝑛𝑡 𝑜𝑓 𝑎𝑟𝑒𝑎 (𝑚4) 
𝐽 = 𝑝𝑜𝑙𝑎𝑟 𝑠𝑒𝑐𝑜𝑛𝑑 𝑚𝑜𝑚𝑒𝑛𝑡 𝑜𝑓 𝑎𝑟𝑒𝑎 (𝑚4) 
E-6. Seal Torque 
Formula used to calculate the torque required to overcome static friction of UHMWPE Seal 
𝑇 = 𝑊 × 𝑙 
Where  
𝑇 = 𝑡𝑜𝑟𝑞𝑢𝑒 (𝑁𝑚) 
𝑊 = 𝑤𝑒𝑖𝑔𝑕𝑡 (𝑁) 
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E-7. Endurance Limit 







𝑘𝑐 = 1 
𝑆𝑒
′ = 0.504𝑆𝑢𝑡  
Where  
𝑆𝑒 = 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 𝑒𝑛𝑑𝑢𝑟𝑎𝑛𝑐𝑒 𝑙𝑖𝑚𝑖𝑡 
𝑘𝑎 = 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 
𝑘𝑏 = 𝑠𝑖𝑧𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 
𝑘𝑐 = 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑓𝑎𝑐𝑡𝑜𝑟 
𝑘𝑑 = 𝑡𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 𝑚𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
𝑘𝑒 = 𝑚𝑖𝑠𝑐𝑒𝑙𝑙𝑎𝑛𝑒𝑜𝑢𝑠 − 𝑒𝑓𝑓𝑒𝑐𝑡𝑠 𝑚𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 
𝑆𝑒
′ = 𝑟𝑜𝑡𝑎𝑟𝑦 − 𝑏𝑒𝑎𝑚 𝑡𝑒𝑠𝑡 𝑠𝑝𝑒𝑐𝑖𝑚𝑒𝑛 𝑒𝑛𝑑𝑢𝑟𝑎𝑛𝑐𝑒 𝑙𝑖𝑚𝑖𝑡 
𝑆𝑢𝑡 = 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 𝑢𝑙𝑡𝑖𝑚𝑎𝑡𝑒 𝑡𝑒𝑛𝑠𝑖𝑙𝑒 𝑠𝑡𝑟𝑒𝑛𝑔𝑡𝑕 
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E-8. Body Mass 
The data captured by Taylor & Walker (2001), relating to femoral loading is quoted in body 
weight units (BW). In order to accurately predict the material stresses in the growth module, 
this unit needed to be quantified.  
𝐵𝑀𝐼 = 𝑚 𝑕2  
Where  
𝐵𝑀𝐼 = 𝑏𝑜𝑑𝑦 𝑚𝑎𝑠𝑠 𝑖𝑛𝑑𝑒𝑥 
𝑚 = 𝑚𝑎𝑠𝑠  𝑘𝑔  
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F-1. Piezo Motor 
F-1-1. Drive Signal 
Print this page 
 
 
SV: SV: Follow up. 
From: "Olle Lindkvist" <Olle.Lindkvist@piezomotor.se> 
To: "Adam PARSONS" <Adam.Parsons@uct.ac.za> 
Date: Tuesday - October 5, 2010 8:41 AM 
Subject:  SV: SV: Follow up. 
Attachments: Mime.822 
Dear Adam, 
Yes you can drive using a square wave. 
 
Best regards 
Olle Lindkvist  
Global Sales Manager 
PiezoMotor AB 
-----Ursprungligt meddelande----- 
Från: Adam PARSONS [mailto:Adam.Parsons@uct.ac.za]  
Skickat: den 4 oktober 2010 11:30 
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Ämne: Re: SV: Follow up. 
Dear Olle, 
The information provided in the spreadsheet is not particularly clear. I would just like 
to know whether it is possible to operate the rotary motor with a square wave? Was 




>>> "Olle Lindkvist"  09/30/10 1:48 PM >>> 
Adam, 
Here are some wave forms. 
Best regards 
Olle Lindkvist  





Från: adam.parsons@uct.ac.za [mailto:adam.parsons@uct.ac.za]  
Skickat: den 30 September 2010 13:47 
Till: Olle Lindkvist 



















I was hoping to establish what possible inputs (voltage waveform) I can supply the 
rotary motor with. 
The standard driver for the motor supplies a sinusoidal waveform to the motor. For 
my application, it is preferable to supply either a square or trapezoidal waveform; is 
the motor capable of operations with such waveforms, or will it be detrimental to 







Cell: 084 011 2919 
E-Mail (1): adam.parsons.84@gmail.com 
E-Mail (2): adam.parsons@uct.ac.za 
________________________________ 
 
From: "Olle Lindkvist"   
Date: Thu, 30 Sep 2010 13:26:45 +0200 
To: Adam PARSONS 
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Dear Adam, 
I want to follow up our previous conversation as I received a messaged from our UK 
distributor.  
Anything I can do for you? 
Best regards 
OLLE LINDKVIST 
Global Sales Manager 
PiezoMotor Uppsala AB 
Stålgatan 14, SE-754 50 Uppsala, Sweden 
Phone: +46 (0)18-489 50 00         Direct phone: +46(0) 18-489 51 71 
Mobil: +46(0)70-514 30 20            Fax: +46 (0)18-489 50 01 
www.piezomotor.com                      E-mail: olle.lindkvist@piezomotor.se   
 
### UNIVERSITY OF CAPE TOWN  
This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our 
website at http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from 
+27 21 650 4500. This e-mail is intended only for the person(s) to whom it is 
addressed. If the e-mail has reached you in error, please notify the author. If you are 
not the intended recipient of the e-mail you may not use, disclose, copy, redirect or 
print the content. If this e-mail is not related to the business of UCT it is sent by the 
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F-1-2. Gamma Sterilisation 
Print this page 
Re: SV: Rotary Piezo Motor 
From: Adam PARSONS 
To: Olle.Lindkvist@piezomotor.se 
BC:  
Date: Friday - June 10, 2011 10:29 AM 
Subject:  Re: SV: Rotary Piezo Motor 
Dear Olle, 
Thank you. 




>>> Olle Lindkvist  06/09/11 8:47 AM >>> 
Dear Adam, 
What may be affected are plastics and epoxy depending on the radiation and energy 
used. Still, we believe it will work although it is hard to estimate the affect on the 
lifetime. 
The plastics used would only be the connector. 























Från: Adam PARSONS [mailto:Adam.Parsons@uct.ac.za] 
Skickat: den 8 juni 2011 18:03 
Till: Olle Lindkvist 
Ämne: Rotary Piezo Motor 
 
Dear Olle, 
I hope you are well. 
What type of piezo ceramics are used in the rotary motor? Alternatively, would the 
motor be capable of withstanding a dose of gamma radiation (when off and not 





### UNIVERSITY OF CAPE TOWN 
This e-mail is subject to the UCT ICT policies and e-mail disclaimer 
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http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from 
+27 21 650 9111. This e-mail is intended only for the person(s) to whom 
it is addressed. If the e-mail has reached you in error, please notify 
the author. If you are not the intended recipient of the e-mail you may 
not use, disclose, copy, redirect or print the content. If this e-mail 
is not related to the business of UCT it is sent by the sender in the 
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G. Patent
G-1. Patent Application .................................................................................G-2 
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Department of Research & Innovation 
                                                                                                          
Research Contracts & IP Services 
University of Cape Town .  Private Bag . Rondebosch . 7701 . South Africa 
Research & Innovation Building . 2 Rhodes Avenue . UCT . Mowbray . 7701 





INTELLECTUAL PROPERTY DISCLOSURE FORM 
 
 
IMPORTANT NOTE ON PUBLIC DISCLOSURE 
 
Please contact RCIPS before making any public disclosure of an invention.  
Failure to do so may result in the loss of rights to patent protection.  Certain forms of 
disclosure can be managed by maintaining confidentially under written agreement 
and RCIPS can assist with this. 
 
Public disclosure occurs through oral presentation at meetings at which the audience 
is not solely comprised of UCT Staff and Students, all forms of publication no matter 
how informal (abstracts, posters, non-accredited journals) as well as by SUBMITTING 
A THESIS for examination.  Special provisions exist, however, for maintaining theses 
confidential for a period.  
 
 
No.  2011/ 



















For any questions please contact: Andrew.Bailey@uct.ac.za  tel 021 650-2425 
 Cynthia.Best@uct.ac.za   tel 021 650-3076 
 IP Services Reception   tel 021 650-4015 
 
Date Submitted:         {Please submit 
electronically} 
 
Invention Title: NON INVASIVE ENDOPROSTHETIC GROWTH CONTROL DEVICE 
 
Contact Inventor:    GEORGE VICATOS 
 
Do any of the Inventors work in an MRC-funded Group, Unit or Centre?     Yes / No 
 
Inventor/s 
PLEASE ADD ADDITIONAL TABLES FOR INVENTORS AS NECESSARY – Include 
Inventors from other institutions – note their affiliation in Department & Group/Unit field. 
 
NB.  Full names and you home address details are required by the Patent Office.   
 
If you leave UCT, please keep our office updated as to your contact details so that we can 
track you for the payment of any royalty income accruing to the inventors. 
* 
FULL names [as per ID 
document] 
GEORGE VICATOS 
Title [Mr/Ms/Prof/Dr] Dr 
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Faculty EBE 
Staff or Student Number 00264733 
Tel no.  021 6502492 
Cell no.  0834243404 
Email address George.vicatos@uct.ac.za 
Residential Address 1 Huguenot Avenue, Oranjezicht, 8001 
Postal address & code if 
external, or UCT internal 
mail delivery address. 
MECHANICAL ENGINEERING DEPARTMENT 
Nationality GREEK (RSA RESIDENT) 
 
FULL names [as per ID 
document] & title: 
SAMUEL ISAAC GINSBERG 
Title [Mr/Ms/Prof/Dr] Mr 
Department & Unit/Group ELECTRICAL ENGINEERING 
Faculty EBE 
Staff or Student 01362217 
Tel no.  021 6505297 
Cell no.  0722072137 
Email Samuel.ginsberg@uct.ac.za 
Residential Address 45 Cottage Mews, Fitzpatric Road, Milneron, 7441 
Postal address & code if 
external, or UCT internal 
mail delivery address. 
ELECTRICAL ENGINEERING DEPARTMENT 
Nationality RSA 
 
FULL names [as per ID 
document] & title: 
ADAM THANE PARSONS 
Title [Mr/Ms/Prof/Dr] Mr 
Department & Unit/Group MECHANICAL ENGINEERING 
Faculty EBE 
Staff or Student 1264906 
Tel no.  021 6502492 
Cell no.  0840112919 
Email adam.parsons @uct.ac.za 
Residential Address 3 Ellerslie Rd, Wynberg, 7808 
Postal address & code if 
external, or UCT internal 
mail delivery address. 
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Share in Intellectual Property Creatorship (add more rows if necessary) 
 
Note UCT inventors should record “UCT” in the Institution column. 
 
Name 


























Name:  University of Cape Town 
 
Address: Lovers Walk 
  Rondebosch 




Courier/Street/Postal Address (for general communication) 
 
Research Contracts & IP Services 
Research & Innovation Building 
University of Cape Town 






Advise RCIPS of any other party, e.g. a funder who may have certain rights to this 
intellectual property (even if they funded only part of the work). 
 
                                                        
1
 An “Inventor” must contribute intellectual property to the inventive step that resulted in the invention.  
An Enabler is not involved in the inventive step, but may have done significant work, as directed by 
the inventors to prove the concept.  Inventors may wish identified Enablers to share in any royalty 
income accruing to the Inventors.  Additional information can be obtained by contacting RCIPS. 
2
 This share is the basis on which the Inventors’ portion of possible royalty income will be shared.  A 




















Summary: What is your invention and what does it do?  Mention its potential commercial or 
societal value and mention the products or services that a company may develop based on 
the technology. (One or two paragraphs) 
 
It is an endoprosthetic device to replace bone tissue to skeletally immature patients. It 
provides length adjustment to limbs (humerus, femur, and tibia) without surgical intervention. 
It requires an electromagnetic signal which is transmitted through the skin. It provides a 
feedback signal from which the extension and the tension of the soft tissues are monitored. 
 
There are very few devices that perform limb lengthening. These devices need minimal 
surgical procedures to lengthen. Only recently, motorised devices were introduced in the 
market, but these utilise permanent magnets internal to the device and cumbersome and 
heavy external induction coils. 
To the contrary, the under development device, utilises the combination of a piezo-motor, 
gearbox and screw-thread to provide a lengthening force of 2000N, while the signal is 




Public Disclosure: (e.g. conference presentation, publication of paper, thesis submission, 
dissertation). 
 
a) Has the invention been disclosed?   
  
 Yes:                                               Date:  
 
 No:  
 
b) Is any public disclosure planned?  
  
 Yes:                                               Date: (Pending patent registration) 
It will be made public once the MSc 




 No:  
 









   
Conference  
Papers 
   





















Presentations    
Posters    
Grant/ Funding 
Proposals 




   
Academic  
Collaborator 
   
Thesis/ 
Dissertations 
 END OF 
AUGUST 
2011 
A SEMINAR MAY BE PLANNED TOO 




Full Technical Description 
Provide a FULL technical description of your invention (nature, purpose and operation) with 
sufficient detail that would enable a skilled person to replicate your invention.  Experimental 
results, or details of prototypes, should be included where available.  This section may be 








What are the advantages/differences of your invention over existing technology, i.e. 
what are the improvements?  Include a brief overview of existing, similar technology (ies). 
 Piezo-motor 
 Electromagnetic transmission for power 
 Feedback on extension 
 The device is impervious to MRI exposure, hence sharp/clear images of surrounding 
tissue can be obtained 
 
What possible extensions, variations or modifications are there? [This assists with 
ensuring that ongoing and future work will be accommodated in the patent specification of 
possible]. 
 
 Measurement of tissue tension 
 Reduction of dimensions of motor/gearbox depending on manufacturers 
 Location of control electronics inside the receiver unit, under the skin rather than 
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In what way(s) is your invention ‘inventive’ or not obvious to people with your 
technical skills?  Describe any surprising effects or outcomes that could not have been 
predicted based on current understanding or theory. 
 
Existing devices use minimally invasive surgery to give access to the extending mechanism. 
Other devices use permanent magnets and an external rotating magnetic field as a driving 
mechanism. 
The feedback on extension is by measuring the position of the devise at successive x-ray 
images. 
 
Prior Art  
 
Please submit a Prior Art Search Report with this Invention Disclosure Form, i.e. a review of 
patents and general literature to confirm the novelty of your invention.  Separate information 





Use of Biological (or other) Materials  
 
Is the invention: 
 
i)  Based on, or derived from, a South African indigenous biological resource of a 
genetic resource? 
  
Yes  No X 
 
ii) Based on, or derived from, traditional knowledge or use 
 
Yes  No X 
 
 
iii) Co-owned with the local community or individual 
 



































d) Do the conditions of transfer permit commercial exploitation and use of the material?  If 






Please list any relevant Confidential Disclosure/Non-Disclosure Agreements.  
 




Source of Research Funding 
 
a) Funding sources:  
 
Funder Amount (R) 





b) Relevant agreements (RCIPS can assist with this): 
 




   
NONE   
   
* UO (University Office) number or Fund number 
 
 
c) Special terms:  
 








Stage of Development 
 
a) What is the current stage of development:  
 
i)  an idea  














G-10 | P a g e  
 
iii)  a working prototype  
 
b) What is still to be done? 
 
 
Next Developments At UCT External  Time 
Required 
Projected Costs 
Test the electronic components under 
gamma radiation and MRI exposure 




Mechanical testing of prototype X  June-July minimal 
Testing of hydraulic seals X  June-July minimal 
Force response 
Temperature response 
X  June-July minimal 




Potential Commercial Partners/Licensees 
 
a) Companies that may be interested in the invention: 
 
 Implant manufacturers of tumour prosthetics 
 
 
b) Existing links with potential commercial partners: 
 
 None yet 
 
 
c) Technical, marketing and investment contacts with knowledge relevant to the potential 
application that could assist with the commercial evaluation of the invention: 
 
 Yes. George Vicatos has and, also there are local and international companies that 
can promote the device. 
 
d) Information on the commercial viability of the invention, e.g. selling price, potential 
markets, or a business plan: 
 
 Selling price: about R250,000 
 National and international market 
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G-2. Technical Description 
 
Overview 
The device is necessary to provide linear extension of Long bones in-vivo for skeletally 
immature patients, achieved through functional components, namely a piezo motor, 
gearbox and screw. The motor provides the necessary driving force, while the gearbox 
increases the torque and the screw provides further gearing as well as converting the 
rotational motion into linear, extended the length.  
The motor is controlled and powered externally, via inductive coupling across the patient’s 
skin. A cable delivers the power to the drive electronics (located immediately behind the 
piezo motor (dwg no. 002)) through a hole in the drive unit casing, sealed by means of 
biocompatible glue.  
Given the operating environment for the device, biologically incompatible components 
(motor electronics, motor and gearbox) are to be completely sealed from the external 
environment (body fluids), while all components in contact with body fluids are of 
biocompatible materials, namely Titanium (Ti6Al4V) and Ultra High Molecular Weight 
Polyethylene (UHMWPE). 
 
Description of Mechanical Extension Device. 
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Component Part No. 
Piezo Motor 001 
Adapter Plate 002 
Transition Shaft 003 
Gearbox 004 
Drive Unit Casing 005 
Spacing Plate 006 
Drive Shaft 007 
Seal 008 
Cover Shaft 009 
Extension Shaft 010 
 
Drive Unit 
The device drive unit consists of a Piezo Legs Rotary Motor (prt no. 001) connected to a 
Wittenstein Cyber Motor GCP 022 196:1 Gearbox (prt no. 004), sourced from separate 
suppliers. A fabricated transition shaft (prt no. 003) facilitates compatibility, connecting the 
motor output shaft and gearbox input, ensuring transfer of power between the motor and 
gearbox. The gearbox output shaft is further modified to a hexagonal shape, allowing 
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fixed to each other by means of an adapter plate (prt no. 002) and mounting screws, 
forming the complete drive unit. 
The drive unit locates within the drive unit casing (prt no. 005), rigidly fixed in position by 
three machine screws. A polished spacing plate (prt no. 006) provides clearance between 
the screw heads and the drive shaft, as well as a low friction contact surface for the rotating 
drive shaft. The drive shaft (prt no. 007) locates within the drive unit casing on the gearbox 
output shaft and against the spacing plate. The contact surfaces between the spacing plate 
and drive shaft are polished to minimise frictional forces. 
Sealing       
A UHMWPE seal (prt no. 008) locates on the drive shaft, against a shoulder within the drive 
unit casing. The liquid seal with the drive shaft is produced by an interference fit. The cover 
shaft (prt no. 009) threads into the drive unit casing, compressing the UHMWPE seal against 
the locating shoulder of the drive unit casing. Additionally, a chamfer at the base of the 
cover shaft thread locks against a corresponding chamfer on the drive unit casing. 
Rotation-linear Conversion 
The extension shaft (prt no. 010) threads onto the drive shaft. Rotation of the extension 
shaft is prevented by screws in the over shaft locating within a groove on the extension 
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The electronic system must perform the following functions under the following conditions: 
1. Provide suitable signals to the piezo motor to make it step. 
2. Allow monitoring of the amount of rotation executed by the motor. 
3. Couple the motor drive energy through the skin of the patient. 
4. Allow medical personnel to set up the amount of rotation (and hence extension) that will 
be executed in a given time period. 
5. Optionally allow for force measurements to be performed and transmitted. 
6. The implanted segment of the system must be tolerant of standard medical procedures 
such as sterilisation and MRI scanning 
 
In order to achieve this, the system has been broken into three parts: viz one internal to the 
patient, one externally applied to the patient on a regular basis and one software program 
that allows configuration of the rest of the system. 
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Inside the patient are the motor, motor drive circuit and power-receiving coil and regulation 
circuit. 
The motor requires four correctly phased electrical signals in order to make it rotate. These 
signals are shown here: 
 
These waveforms are supplied repeatedly to the motor to rotate it. In addition, it is very 
useful to have feedback to measure the rotation of the motor. This is done by drawing a 
















G-16 | P a g e  
 
The energy to drive the system is supplied inductively from outside the body. According to 
the principles of electrical transformers, drawing a current impulse from the power supply 
within the body will cause a similar current impulse to be drawn from the unit outside the 
body. Thus, by monitoring the current consumption of the external unit, it is possible to 
determine when the motor has taken four 'steps' of rotation. 
 
Given the need to withstand ionizing radiation during the sterilisation process, conventional 
microcontroller technology is not feasible as the radiation causes the contents of many 
memory types to be damaged. This includes the Flash and EEPROM used to store programs 
in the vast majority of microcontroller devices. For this reason, a different approach was 
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The charge coil is a coil of copper wire implanted just under the patient’s skin. This coil 
connects to D25 and D26, which convert the alternating current from the coil to direct 
current. C7, C9, C10 and C11 store this energy briefly for use by the circuit. R18 and D2 
regulate the voltage supplied to the rest of the circuit. 
IC5B, R19 and D3 detect when the power supply has reached a high enough voltage to 
successfully turn the motor. When this happens a voltage pulse appears at the point 
labelled 'start pulse'. 
The four cascaded circuits following the start pulse signal each serve as a time delay. Each 
time delay starts the following time delay and each time delay circuit's output drives one 
phase of the motor. 
IC4A is a delay circuit which causes the transistor T1 to conduct, which draws a current 
impulse from the charge coil. In so doing, it discharges the voltage storage capacitors C7, C9, 
C10 and C11. When these capacitors recharge after the current impulse they cause the 
entire process to restart. Thus the waveforms above are reproduced for as long as the 
charge coil is exposed to a suitable alternating magnetic field.  
By virtue of the fact that operation of this circuit is hard-wired rather than being controlled 
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Should in-vivo force measurements be required, this system could be enhanced by 
measuring the force experienced by the titanium components by attaching strain gages to a 
part which experiences extension force and measuring the strain (fractional compression) of 
that part. This information could be transmitted out through the skin either using 
conventional radio techniques (with power supplied through the charge coil) or by coded 
patterns of current impulses in an enhancement of the scheme shown above. 
 
External to the patient 
This unit is designed to strap on to the patient so that it can supply an alternating magnetic 
field to the internal charge coil. In addition, it will measure the number of steps taken by the 
motor and ensure that the motor rotates the correct number of times in a given period. 
Because this unit is not implanted in the patient there is no need for it to be radiation 
tolerant. 
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A block diagram of the external system is shown here: 
 
This system is controlled by a microcontroller. The microcontroller can be connected to a 
computer through some interface, typically USB. When the device is connected it will be 
informed, via the interface, of the required extension parameters and will store these in the 
memory device. 
An RFID reader may optionally be present and this would be used to identify that the 
correct external device is being applied to the correct endoprosthetic device.  
An LCD and buttons may be present for the user to start and stop extension (within the set 
extension parameters) and to inform the user of the progress of the extension.  
 
The drive coil needs to be driven with an alternating current at high frequency. The charge 
coil produces an output proportional to rate of change of magnetic field strength, and thus 
the need for alternating current with higher coupling efficiencies obtained with increasing 
drive frequency. The H bride is a set of four power switches (typically transistors) which are 
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with the power supply to the H bridge. Current drawn from the H bridge produces a 
proportional voltage across the resistor. This voltage has two main frequency components. 
The first of these is at the drive frequency (and its harmonics) and the second is the 
reflected current from the current impulses. These signals may be distinguished by their 
frequency. The reflected impulses will be below 1 kHz (as governed by the operation of the 
motor) whereas the drive frequency will typically be selected to be in the 100 kHz to 1 MHz 
region. The low pass filter removes higher frequencies and thus outputs a signal which the 
microcontroller can use to count the number of steps that the motor has taken. This is then 
controlled according to a flowchart (extra attachment) to produce the desired extension. 
Software for Configuration 
Medical personnel will need to instruct the external device as to the amount of extension 
required, and the time profile over which that extension is applied. 
This is done through a computer application. An example of the user interface for such a
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Once the extension information has been entered, the settings would be downloaded 
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H. Miscellaneous
H-1. Irradiation Certificate
Appendix H 
